Department of Pharmacy Practice

2020 Scholarly Activity Report

The activities listed below are by members of the Department of Pharmacy Practice and span the period from January 1, 2020 - December 31, 2020.

* ACPHS faculty denoted in bold.

ACCOMPLISHMENTS

Awards

• Jessica Farrell awarded the New York State Chapter of the American College of Clinical Pharmacy Clinical Practitioner of the Year 2020
• Amy Yanicak is the AACP 2020 Scholarship of Teaching and Learning Grant Recipient (May 2020)
• Lizz Higdon was awarded the NACADA 2020 Region 1 excellence in advising- Faculty advisor.
• Andy Flynn won the 2019-2020 Professional Organization Advisor of the Year, 2020
• Jo Carreno won the ACPHS Faculty Advisor of the Year for Albany AND graduated from the Master in Public Health Program at Wayne State University, 2020
• Amy Yanicak received Outstanding Faculty Advisor for the Vermont campus, 2020
• Lizz Higdon received Teacher of the year for the Vermont campus, 2020
• Amy Yanicak is the Recipient of 2020-2021 AACP Scholarship of Teaching and Learning (SOTL) Grant for project:  Impact of small group interprofessional simulation experiences on a large-scale response to emergency situations, $4000
• Lizz Higdon was awarded the NACADA 2020 Region 1 excellence in advising- Faculty advisor.
• Courtney Caimano was awarded the SGA President’s Award at the Leadership Banquet

Appointments

• Katie Cardone  is now Continuing Professional Development Committee member, American Society of Nephrology, 2020
• Jessica Farrell has been appointed to the Rheumatology Advanced Practice Providers (RhAPP) Steering Committee, 2020
• Katie Cardone was appointed Co-Chair, Nephrology Practice Standards Committee, Advancing Kidney Health Through Optimal Medication Management. 2020 – present.
• Amanda Engle was appointed to the Albany Medical College Curricular Assessment Team, 2020
• Amanda Engle was elected Chair-Elect of the ACCP Pain and Palliative Care PRN, 2020
• Amy Yanicak and Emily Sutton were appointed medical directors for COVID19 testing on the ACPHS Vermont Campus, 2020
• Darren Grabe was appointed medical director for the COVID19 testing on the ACPHS Albany Campus, 2020
• Amanda Engle has been appointed Co-Chair of the Interprofessional Education Steering Committee, 2020
• Jacqueline Cleary was granted CPIC Membership (Clinical Pharmacogenomics Implementation Consortium)
• Jessica Farrell was named 2020 New York State Chapter of the American College of Clinical Pharmacy Clinical Practitioner of the Year. 
• Abby Boire was named Interim Pharmacy Program Director for the Vermont Campus, 2020
• Jessica Farrell was named Albany Faculty Advisor of the year, 2020
• Lizz Higdon was named Vermont Outstanding faculty advisor of the year, 2020
• Kelly Bach was named Professional Organization Advisor of the year and Preceptor of the year, 2020
• Lee Anna Obos was named Club advisor of the year, 2020
• See-Won Seo was named Chair of the AACP Global Pharmacy Special Interest Group for 2020-2021
• See-Won Seo was named Co-Lead of the CAP Government Relations Group, 2020.
• See-Won Seo was appointed to the AACP Rules and Resolutions Committee for the Council of Faculties, 2020
• See-Won Seo was selected for Community Grants Review Committee for Korean American Community Foundation, 2020

Presentations

NATIONAL

Cardone KE, Meaney C. The Role Of The Pharmacist In Chronic Kidney Disease. Webinar For Pharmacists And Healthcare Providers. NephU Webinar Platform, Otsuka Pharmaceuticals, October 2020.

Cardone KE. Medication Reconciliation: In-Center/Inpatient Communication: Hand-Off Reporting and Med Reconciliation Session. National Kidney Foundation 2020 Spring Clinical Meeting, Virtual Conference, March 2020.

Cardone KE. CKD Pharmacology 101. Council on Renal Nutrition (CRN) Pre-Conference: Essentials Of Nutrition Practice For Chronic Kidney Disease. National Kidney Foundation 2020 Spring Clinical Meeting, Virtual Conference, March 2020.

Cardone KE. Nephrology Review for The Ambulatory Care Pharmacist. Review and Recertification Course For Board Certified Ambulatory Care Pharmacists (BCACP). American College of Clinical Pharmacy/American Society Of Health-System Pharmacists Conference, March 2020, Las Vegas, NV.

Intravenous Compatibility of Ceftazidime-Avibactam and Aztreonam Using Simulated and Actual Y-site Administration. O'Donnell JN, Xu A, Lodise TP. Clin Ther. 2020 Aug;42(8):1580-1586.e2. doi: 10.1016/j.clinthera.2020.06.005. Epub 2020 Jul 16. PMID: 32684326

Approach to the Treatment of Patients with Serious Multidrug-Resistant Pseudomonas aeruginosa Infections. O'Donnell JN, Bidell MR, Lodise TP. Pharmacotherapy. 2020 Sep;40(9):952-969. doi: 10.1002/phar.2449. Epub 2020 Aug 17. PMID: 32696452 Review.

Assessment of mortality stratified by meropenem minimum inhibitory concentration in patients with Enterobacteriaceae bacteraemia: A patient-level analysis of published data. O'Donnell JN, Rhodes NJ, Biehle LR, Esterly JS, Patel TS, McLaughlin MM, Hirsch EB. Int J Antimicrob Agents. 2020 Feb;55(2):105849. doi: 10.1016/j.ijantimicag.2019.11.006. Epub 2019 Nov 23. PMID: 31770628

Plumadore E, Cabral K. Impact of the Implementation of a Sodium-Glucose Cotransporter-2 Inhibitor Protocol by a Pharmacist in a Private Cardiology Practice.
Presented at ACC Chicago virtual meeting, March 2020.
Presented at NYSCHP Annual meeting (virtual), April 2020.

Park SK, Woolley AB, Seo SW.  Measuring the Heartbeat of the Student Learning Culture: What They Do and How We Can Adapt. Co-presented a continuing education (“podium”) presentation to pharmacists at the American Association Colleges of Pharmacy (AACP) Annual Meeting, Long Beach, CA, July 2020. (virtual due to COVID-19).

Cardone KE. Medication Reconciliation in Patients with ESRD. 2020 CMS Quality Conference, February 2020, Baltimore, MD.

Brodeur MR, Choosing Wisely Statements: A 2020 Update from the Deprescribing Task Force. American Society of Consultant Pharmacist Annual Meeting, Kissimmee, Florida. November 15, 2020.

Bach K, St. John T.  Impact of an Antimicrobial Stewardship Program on Pharmaceutical Costs.  ASHP Midyear Clinical Meeting 2020.

Kim E, Bach K, St. John T.  Perceptions of healthcare providers regarding antimicrobial stewardship in a community teaching hospital in the United States.  ASHP Midyear Clinical Meeting 2020.

Jessica Farrell. Clinical Trials of Currently Approved and Emerging JAK Inhibitors for RA. Presented in collaboration with Drs. Roy Fleischmann, Jeffrey Curtis, Elizabeth Kirchner and Eric Ruderman an ACPE-accredited CE webinar program as part of Haymarket Medical Education Continuing Education Program. Available at www.mycme.com. 2020.

Jessica Farrell. Scleroderma Medications: What works? How Can I Get It?  Presented to patients, caregivers and providers as a webinar for the Scleroderma Foundation Virtual University Patient Education Summer Series. July 15, 2020.

Jessica Farrell. Caring for Immunosuppressed Patients on Non-specialist Wards – What Every Specialist Wants You to Know:  Rheum for Improvement in Managing Patients with Rheumatoid Disease. Presented to pharmacists, an ACPE-accredited 1.5-hour CE program as part of 2020 American College of Clinical Pharmacy (ACCP) Virtual Annual Meeting. October 26, 2020.

Jessica Farrell.  Pharmacist-Led Multidisciplinary Approach to Opioid Tapering in a Large Private Rheumatology Practice. Oral abstract presented to rheumatologists and rheumatology health professionals at the American College of Rheumatology 2020 Annual Scientific Meeting.  November 6, 2020.  

Park SK, Woolley AB, Seo SW. Measuring the Heartbeat of the Student Learning Culture: What They Do and How We Can Adapt. Co-presented a continuing education(“podium”) presentation to pharmacists at the American Association Colleges of Pharmacy (AACP) Annual Meeting, Long Beach, CA, July 2020 (virtual).

Seo, SW; Park, S;  Woolley, A:  AACP Annual Meeting 2020 proposal accepted: “Measuring the heartbeat of the student learning culture: What they do to supplement learning and how you can adapt.”

Eun Hae Kim, PharmD, Kim E, Bach K, St. John T. Perceptions of healthcare providers regarding antimicrobial stewardship in a community teaching hospital in the United States. American Society of Health-System Pharmacists Midyear Clinical Meeting; Virtual. December 2020.

Bach K, St. John T. Impact of an Antimicrobial Stewardship Program on Pharmaceutical Costs. ASHP Midyear Clinical Meeting. December 2020.

REGIONAL

Seo, SW. Utilizing Pharmacists for Management of Chronic Conditions & Patient Engagement, focusing on Diabetes and Cardiovascular Disease Prevention and Control. A panel presentation at the Community Health Care Association of NY State (CHCANYS) Meeting, Albany, NY, January 2020.

Watson, A. Future of Pharmacy. Accepted Students Day, ACPHS, Albany, NY. May 2020.

Watson, A. Timely Topics in Hypertension. Continuing Pharmacy Education. ACPHS, Albany, NY. April 2020.

Seo, SW; Abionola, W:  Served as invited panelist for the CHCANYS’ Utilizing Pharmacists for Management of Chronic Conditions and Enhanced Patient Engagement event on 1/16/20

Farrell JF. Scleroderma Medications: What Works?  How Can I Get It?. Presented to patients, caregivers and providers at the Scleroderma Foundation South Carolina Chapter 10th Annual Amy K. Parrish Patient Education Conference.  Charleston, SC. February 8, 2020.

ABSTRACTS

Hossain S, Naber M, Yacobucci MJ. A Retrospective Observation Study of Low Fixed Dose Rasburicase for the Treatment of Tumor Lysis Syndrome. Hematology/Oncology Pharmacy Association (HOPA) 2020 Annual Conference, Tampa, Florida, March 11-14, 2020. Poster TR9.

Farrell JF, Miller ME, Hennig K. Powers KE, Kwon S, Moyer DH, French KL, Citta AM, Cleary JH.  Pharmacist-Led Multidisciplinary Approach to Opioid Tapering in a Large Private Rheumatology Practice. Oral abstract presentation at the American College of Rheumatology 2020 Annual Scientific Meeting.  November 5-9, 2020. 

Babowicz F, LaPlante R, Mitchell C, George M, Carreno JJ. Impact of Accelerate Pheno System and Multidisciplinary Antimicrobial Stewardship Team on Early Utilization of Antibiotics in Gram-Negative Bacteremia. Abstract # SP-370. Virtual Poster Presentation. Virtual Meeting (due to COVID-19). December 2020.

LaPlante R, Babowicz F, Mitchell C, George M, Carreno JJ, Impact of Accelerate Pheno System and a Multidisciplinary Antimicrobial Stewardship Program on Gram-Negative Sepsis Outcomes. Abstract # SP-382. Virtual Poster Presentation. Virtual Meeting (due to COVID-19). December 2020.

Seo SW, Law M, Kahaleh AK, Gleason SG, Toyin T. Closing the gap on global competencies for pharmacy education using ASHP and EAHP statements. An online, recorded poster presentation to pharmacists at the International Pharmaceutical Federation World Congress, Seville, Spain, Sept 2020 (virtual).

Yacobucci M, Lombardi CL, Briceland LL.  Characterization and Impact of Pharmacy Student Participation on Hematology/Oncology APPE Rotations in Varied Practice Settings. Hematology/Oncology Pharmacy Association (HOPA) 2020 Annual Conference, Tampa, Florida, March 11-14, 2020. Poster PM08. 

PUBLISHED ABSTRACTS

*Lodise T, Chopra T, Nathanson B, Sulham. Epidemiology of Complicated Urinary Tract Infections (cUTIs) Presenting in Emergency Departments Across the United States (US). Abstract #1673. Poster presentation at IDweek2020™. October 21, 2020. Presenter: Lodise

*Lodise T, Chopra T, Nathanson B, Sulham. Hospital Admission Patterns in Adult Patients with Complicated Urinary Tract Infections (cUTIs): Identification of Potentially Avoidable Hospital Admissions Across United States (US) Hospitals. Abstract #1683. Poster presentation at IDweek2020™. October 21, 2020. Presenter: Lodise

*Lodise T, Puzniak L, Wei R, Im TM, Chen LH, Tartof S. Outcomes of Critically Ill Adults, Hospitalized Patients (Pts) with Pseudomonas aeruginosa (PSA) Hospital- and Ventilator-Associated Pneumonia (HAP/VAP) Who Received an Active Anti-Pseudomonal β-Lactam (ASPB): Does “S” Equal Success in the Presence of Resistance to other ASPB? Abstract #1623. Poster presentation at IDweek2020™. October 21, 2020. Presenter: Lodise

*Rodriguez M, Chitra S, Wright K, Lodise T. Targeted Substitution of Omadacycline in Place of Standard of Care for CABP Treatment is Associated with a Risk Reduction of Clostridioides difficile Infection and Financial Cost Savings in the Acute Care Setting. Abstract #1492. Poster presentation at IDweek2020™. October 21, 2020. Presenter: Rodriguez

*Smith NM, Cheng L, Boissonneault KD, Holden PN, Bulitta JG, Bonomo RA, Kreiswirth BN, Tsuji BT. Things that go Bump in the Night: Combating Klebsiella pneumoniae co-producing New Delhi metallo-beta-lactamase (NDM) and Mobile Colistin Resistance (MCR). Abstract #1325. Poster presentation at IDweek2020™. October 21, 2020. Presenter: Smith

*Lapensee K, Le H, Villano S, Lodise T. Epidemiology of Clostridioides difficile infections among hospitalised community-acquired pneumonia patients who received empiric treatment with ceftriaxone plus a macrolide. Abstract # 1764. Poster presentation at 30th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). April 2020. Presenter: Lodise

*O’Donnell N, Putra V, Belfiore G, Maring B, Young K, Lodise T. In vitro activity of imipenem-relebactam plus aztreonam against metallo-β-lactamase producing Pseudomonas aeruginosa. Abstract # 5478. Poster presentation at 30th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). April 2020. Presenter: O’Donnell

*O’Donnell JN, DeMari SR, Patel N. Optimal Treatment of Candidemia: A Meta-Analysis Comparing Outcomes between Echinocandins and Azole Antifungals. Accepted abstract. American Society for Microbiology’s Microbe Online. June 2020.

*Lodise T, Scheetz M, Carreno JJ, Holland T. Vancomycin for patients with MRSA bloodstream infections (BSIs) is nephrotoxic even within the recommended area under the curve (AUC) therapeutic exposure range. Abstract # 5421. Poster presentation at 30th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). April 2020. Presenter: Lodise

*Lodise T, Bassetti M, Ferrer R, Naas T, Niki Y, Paterson D, Zeitlinger M, Tillotson G, Echols R. Comparison of 28-day mortality rates of recently completed prospective, randomised treatment studies of adult patients with carbapenem-resistant Gram negative bacterial infections. Abstract # 2497. Poster presentation at 30th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). April 2020. Presenter: Lodise

WEBINARS

O’Donnell, JN. Treating patients with MDR Pseudomonas aeruginosa infections- Episode 39        ACCP Journals Podcast 2020Completed/Published FALL 2020

Garrison GD. Preceptor Training:  Supporting Self-Directed Learning Goals in Experiential Education.
ACPHS.  1-hour live CE program Wed Oct 28.2020

Garrison GD. Importance of Vaccines. Roman Catholic Diocese of Albany - 2020 Virtual Health Fair.
30-minute virtual presentation with Q/A.  Nov 5, 2020.

Carreno JJ, “Risks of Screening and Treating Asymptomatic Bacteriuria in a Post Antibiotic Era,” New York State Council of Health-Systems Pharmacy 2020 Infectious Diseases Webinar.

INVITED

Invited presentation: Brodeur MR. Choosing Wisely Statements: A 2020 Update from the Deprescribing Task Force. American Society of Consultant Pharmacist Annual Meeting, Kissimmee, Florida. November 15, 2020.

Seo, SW. Closing the gap on global competencies for pharmacy education using ASHP and EAHP statements. An online, recorded poster presentation to pharmacists at the International Pharmaceutical Federation World Congress, Seville, Spain, Sept 2020 (virtual due to COVID-19).

Cleary, J. Pharmacist-Led Multidisciplinary Approach to Opioid Tapering in a Large Private Rheumatology Practice.  American College of Rheumatology Oral Virtual Presentation ACR November 2020.

Cleary, J. A Pharmacists' Introduction to Clinical Pharmacogenomics.  Continuing Education. NYS ACCP Virtual Presentation November 2020.

Cleary, J. Timely Topic on OUD Guidelines and the impact to the COVID-19 patient populations.  Continuing Education. Albany College of Pharmacy and Health Sciences Virtual Presentation October 2020.

Cleary, J. An Introduction to Clinical Applications of Pharmacogenomics Part I & Part II.  Continuing Education.  Albany Medical Center Psychiatry Virtual Presentation Grand Rounds October 2020.

Caimano CR, Briceland LL. Easy as 1, 2, 3: Assessing Levels of Entrustability on Advanced Pharmacy Practice Experiences. AACP Annual Meeting: Virtual Pharmacy Education 2020.

Engle, A, “Clinical Pearls for Safe & Effective Use of Buprenorphine in the Ether Dome.” Massachusetts General Hospital Palliative Care and Geriatrics Grand Rounds, January 2020

Lodise, TP. Importance of Applying Real-World Data for Antimicrobials in Clinical Practice. Invited Presentation. IDWeek2020™: A Joint Meeting of IDSA, SHEA, HIVMA, and PIDS. Session Type: Satellite Symposium. October 24, 2020. Virtual Webinar.

Lodise, TP. Key Practice Changes in the Revised Vancomycin Consensus Guidelines and Potential of Combination Therapy. Invited Presentation. Sunovion sponsored Other Learning Activity. June 10, 2020. Virtual Webinar.

Lodise, TP. Implementing the New Vancomycin Guidelines: What You Need to Know. Invited Presentation. DoseMeRX™ Webinar. June 3, 2020. Virtual Webinar.

Lodise, TP. Vancomycin Intervention. Invited Presentation. Department of Veterans Affairs, Employee Education System and Pharmacy Benefits Management (PBM). May 27,2020. National Webinar.

Lodise, TP. Updates in Treatment of Patients with Serious MRSA Patients: Vancomycin Dosing and Monitoring and Potential Role of Combination Therapy. Invited Presentation. Infectious Diseases Grand Rounds at Health Sciences Centre and St Boniface Hospital, University of Manitoba. Winnipeg, Manitoba. January 15, 2020.

VIRTUAL POSTER PRESENTATIONS & PUBLISHED MEETING ABSTRACTS 

Martinez T, Briceland LL. Exploring the Professionalization Impact of Pharmacy Expert Career Advice Upon Student Pharmacists. 2020 ASHP Midyear Clinical Meeting (virtual). Student Poster SP-384. 

Briceland LL, Caimano CR, Rosa S, Jablanski C, Veselov M.  Post-APPE structured self-reflections: Characterization of impactful learning themes and evidence of actionable professional development plans.  AACP Annual Meeting: Virtual Pharmacy Education 2020.

Briceland LL, Bach K, Rosa SW, Martin Z, Brewer JM, Grabe D.  Beyond the White Coat and Professionalism:  Engendering Professional Identity Formation in Student Pharmacists. AACP Annual Meeting: Virtual Pharmacy Education 2020. School Poster.

Park SK, Woolley AB, Seo SS. Use of supplemental online resources for learning by pharmacy students. Poster presented at: American Association of Colleges of Pharmacy Annual Meeting; July 2020; Long Beach, California (virtual)

Seo SS, Law M, Kahaleh A, Gleason S, Tofade T. Closing the gap on global competencies for pharmacy education using ASHP and EAHP statements. Poster presented at: International Pharmaceutical Federation World Congress; Sept 2020; Seville, Spain (virtual)

POSTERS

Youssef Bessada, PharmD Candidate 2020; Madyson Allard, PharmD Candidate 2020, Allison Gorseth, PharmD Candidate 2020, Victoria Fenton, PharmD Candidate 2022, Eliane Thao Le Van Long, PharmD Candidate 2021, Reid LaPlante, PharmD Candidate 2021, Angela Dominelli, BS, MBA, PhD, Jane K. Boyd, RPh, CDE. Pharmacy Student-led Peer-to-Peer Education on the Opioid Epidemic on College Campuses.  Poster Presentation.  Annual Meeting of American Pharmacists Association, March 11-15, 2020. 

Murray B, Watson A. Reimbursement for Clinical Services Provided by Pharmacists via Telehealth. MidYear Clinical Meeting, Virtual. December 2020. (Poster)

Gamelli A, Yu D, Cleary J.  Trending Prescription Opioid Related Deaths by State Following Legalization of Medical Cannabis for Chronic Pain Management and Opioid Use Disorder Indications.  ASHP Midyear Clinical Meeting Virtual Poster Session, December 2020, virtual presentation.

Miller M, Hennig K, Cleary J, Kwon S, Citta A, French K, Moyer D, Powers K, Farrell J.  Pharmacist Led Multidisciplinary Approach to Opioid Tapering in a Large Private Rheumatology Practice.  NYSCHP Virtual Poster Session, April 2020, virtual presentation.   

Clark L, Lewansowski E, Watson A, Caimano C. Impact of Virtual Learning on Ambulatory Care Advanced Pharmacy Practice Experiences. MidYear Clinical Meeting, Virtual. December 2020. (Poster)

Conde M, Giroux D, Roberts T, Yanicak A. Patient satisfaction with virtual inhaler teaching. 54th ASHP Midyear Clinical Meeting. Online. December 6-10, 2020. Abstract # 950682.Session: Student Posters

Frevele K, Joh Y, Gilchrist H, Kachou B, Baig H, Yacobucci M, Zhou Y, Engle A. Comparison of Virtual and In-Person Inter-professional Education with Pharmacy and Medical Students. American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting 2020.

Yacobucci M, Lombardi CL, Briceland LL, Zeszotarski P.  Characterization and Impact of Pharmacy Student Participation on Hematology/Oncology APPE Rotations in Varied Practice Settings. New York State Council of Health-system Pharmacists 2020 Annual Assembly, April 20-25, 2020.

PublicationS

NATIONAL

Yu J, McKenna VA, Dumyati GK, Lubowski TJ, Carreno JJ. Antibiotic Prescribing in New York State Medicare Part B Beneficiaries Diagnosed With Cystitis Between 2016 and 2017. Open Forum Infect Dis. 2020 Jan 4;7(1):ofz544.

Law M, Seo SW, Kahaleh AA, Gleason SE, Toyin T. Evaluation of the crosswalk between the ACPE standards and the FIP Nanjing statements. Pharmacy Education. 2020;20(1):52-5

Seo SW, Ombengi D, Sultan D, et al. An ethics-based approach to global health research, part 1: building partnerships in global health. Res Social Adm Pharm. 2020;16(11):1574-1579

Drame I, Kahaleh A, Connor S, Seo SW, et al. An ethics-based approach to global health research, part 3: Emphasis on partnership funding. Res Social Adm Pharm. 2020;16(11):1588-1596

Kennedy DR, Harrell TK, Lodise NM, Mattingly TJ, Norenberg JP, Ragucci K, Ranelli P and Stewart AS. Current Status and Best Practices of Shared Governance within US Pharmacy Programs. American Journal of Pharmaceutical Education (AJPE). 2020.

Cieri-Hutcherson N, Brock Harris J, Karaoui L, Lakdawala L, Lodise NM, Stone R, Vernon V. Infertility Management and Pharmacotherapy: What Every Pharmacist Should Know. Journal of Pharmacy Practice (JPP). 2020.

Lincoln K, Stevens RW, Carreno JJ. Diagnosed With Cystitis Between 2016 and 2017. Open Forum Infect Dis. 2020 Jan 4;7(1):ofz544. “Many Platforms Offer Rapid Detection in Bloodstream Infections.” Pharmacy Times. 2020. Sep;

Wagner JL, Carreno JJ, Kenney RM, Kilgore PE, Davis SL. Antimicrobial Stewardship Metrics that Matter. Infectious Diseases in Clinical Practice 28 (2), 89-93

Mataraza A, Gamelli A, Cleary J.  An Updated Look at the COVID-19 Vaccine Candidates- Storage, Distribution, and Barriers to Access.  Guest blog article.  Posted December 16, 2020: https://paindr.com/an-updated-look-at-the-covid-19-vaccine-candidates-storage-distribution-and-barriers-to-access/

Horan E, Healey A, Cleary J.  Pharma Protects Patients Against Government: A COVID Vaccine Paradigm Shift..  Guest blog article.  Posted November 20, 2020: https://paindr.com/pharma-protects-patients-against-government-a-covid-vaccine-paradigm-shift/

Bettinger J, Cleary J, Fudin J.  Amid COVID-19 Crisis, Pain Therapeutics Telehealth Services by Pharmacist Clinicians Fill Unique Void and Mitigate Risk.  Medicine Access @ Point of Care 2020 August https://doi.org/10.1177/2399202620947035.   

Bettinger J, Cleary J.  The Rise in Tianeptine Abuse: Our Next Kratom Problem?  Practical Pain Management 2020 March/April 20(2): 61-64.

Butler DA, Rana AP, Krapp F, et al. Optimizing aminoglycoside selection for KPC-producing Klebsiella pneumoniae with the aminoglycoside-modifying enzyme (AME) gene aac(6’)-Ib. J Antimicrob Chemother. 2021;76(3):671-679. doi:10.1093/jac/dkaa480

Butler DA, Biagi M, Gupta V, et al. Development of a 51-hospital Chicagoland regional antibiogram and comparison to local hospital and national surveillance data. Infect Control Hosp Epidemiol. 2020;41(12):1409-1418. doi:10.1017/ice.2020.334

Hossain S, Naber M, Yacobucci MJ. A Retrospective Observation Study of Low Fixed Dose Rasburicase for the Treatment of Tumor Lysis Syndrome. Hematology/Oncology Pharmacy Association (HOPA) 2020 Annual Conference, Tampa, Florida, March 11-14, 2020. Poster TR9.

Watson A.  COVID-19 Prompts Identification of New Clinical Service Opportunities. Clinical Pharmacy in Action – American College of Clinical Pharmacy. May 2020.

Watson A, Guay K, Ribis D. Assessing the Impact of Clinical Pharmacists on Naloxone Co-Prescribing in the Primacy Care Setting. American Journal of Health-System Pharmacy, Volume 77, Issue 7, 1 April 2020, Pages 568–573.

*Avedissian SN, Pais G, Liu J, O'Donnell JN, Lodise TP, Neely M, Prozialeck WC, Lamar PC, Becher L, Scheetz MH. The Pharmacodynamic-Toxicodynamic Relationship of AUC and CMAX in Vancomycin Induced Kidney Injury in an Animal Model. Antimicrob Agents Chemother. 2020 Dec 14:AAC.01945-20. doi: 10.1128/AAC.01945-20. Epub ahead of print. PMID: 33318004.

*Lodise TP, Li J, Gandhi HN, O'Brien G, Sethi S. Intraclass Difference in Pneumonia Risk with Fluticasone and Budesonide in COPD: A Systematic Review of Evidence from Direct-Comparison Studies. Int J Chron Obstruct Pulmon Dis. 2020 Nov 11;15:2889-2900. doi: 10.2147/COPD.S269637. PMID: 33204085; PMCID: PMC7667513.

*Lodise TP, Van Wart S, Sund ZM, Bressler AM, Khan A, Makley AT, Hamad Y, Salata RA, Silveira FP, Sims MD, Kabchi BA, Saad MA, Brown C, Oler RE Jr, Fowler V Jr, Wunderink RG. Pharmacokinetic and Pharmacodynamic Profiling of Minocycline for Injection Following a Single Infusion in Critically Ill Adults in a Phase IV Open-Label Multi-Center Study (ACUMIN). Antimicrob Agents Chemother. 2020 Nov 9:AAC.01809-20. doi: 10.1128/AAC.01809-20. Epub ahead of print. PMID: 33168615.

*Lodise TP, Kanakamedala H, Hsu WC, Cai B. Impact of Incremental Delays in Appropriate Therapy on the Outcomes of Hospitalized Adult Patients with Gram-negative Bloodstream Infections: "Every day matters". Pharmacotherapy. 2020 Sep;40(9):889-901. doi: 10.1002/phar.2446. Epub 2020 Aug 18. PMID: 33112456.

*Bassetti M, Echols R, Matsunaga Y, Ariyasu M, Doi Y, Ferrer R, Lodise TP, Naas T, Niki Y, Paterson DL, Portsmouth S, Torre-Cisneros J, Toyoizumi K, Wunderink RG, Nagata TD. Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial. Lancet Infect Dis. 2020 Oct 12:S1473-3099(20)30796-9. doi: 10.1016/S1473-3099(20)30796-9. Epub ahead of print. PMID: 33058795.

*Lodise T, Yang J, Puzniak LA, Dillon R, Kollef M. Healthcare Resource Utilization of Ceftolozane/Tazobactam Versus Meropenem for Ventilated Nosocomial Pneumonia from the Randomized, Controlled, Double-Blind ASPECT-NP Trial. Infect Dis Ther. 2020 Sep 30:1–14. doi: 10.1007/s40121-020-00343-0. Epub ahead of print. PMID: 32996064; PMCID: PMC7524640.

*Yasmin M, Hanrahan J, Marshall S, Lodise TP, Chen L, Perez F, Kreiswirth B, Bonomo RA. Using Therapeutic Drug Monitoring to Treat KPC-Producing Klebsiella pneumoniae Central Nervous System Infection With Ceftazidime/Avibactam. Open Forum Infect Dis. 2020 Aug 18;7(9):ofaa349. doi: 10.1093/ofid/ofaa349. PMID: 32964066; PMCID: PMC7491706.

*Lodise TP, Van Le H, LaPensee K. Hospital Admission Patterns in Adult Patients with Community-Acquired Pneumonia Who Received Ceftriaxone and a Macrolide by Disease Severity across United States Hospitals. Antibiotics (Basel). 2020 Sep 4;9(9):577. doi: 10.3390/antibiotics9090577. PMID: 32899697; PMCID: PMC7557926.

*Patel N, Stornelli N, Sangiovanni RJ, Huang DB, Lodise TP. Effect of Vancomycin-Associated Acute Kidney Injury on Incidence of 30-Day Readmissions among Hospitalized Veterans Affairs Patients with Skin and Skin Structure Infections. Antimicrob Agents Chemother. 2020 Sep 21;64(10):e01268-20. doi: 10.1128/AAC.01268-20. PMID: 32718970; PMCID: PMC7508587.

*Alosaimy S, Murray KP, Zasowski EJ, Morrisette T, Lagnf AM, Lodise TP, Rybak MJ. Vancomycin Area Under the Curve to Predict Timely Clinical Response in the Treatment of Methicillin-resistant Staphylococcus aureus Complicated Skin and Soft Tissue Infections. Clin Infect Dis. 2020 Jul 27:ciaa1039. doi:10.1093/cid/ciaa1039. Epub ahead of print. PMID: 32716506.

*O'Donnell JN, Xu A, Lodise TP. Intravenous Compatibility of Ceftazidime-Avibactam and Aztreonam Using Simulated and Actual Y-site Administration. Clin Ther. 2020 Aug;42(8):1580-1586.e2. doi: 10.1016/j.clinthera.2020.06.005. Epub 2020 Jul 16. PMID: 32684326.

*Lodise TP, Izmailyan S, Olesky M, Lawrence K. An Evaluation of Treatment Patterns and Associated Outcomes Among Adult Hospitalized Patients With Lower-Risk Community-Acquired Complicated Intra-abdominal Infections: How Often Are Expert Guidelines Followed? Open Forum Infect Dis. 2020 Jun 19;7(7):ofaa237. doi: 10.1093/ofid/ofaa237. PMID: 32676511; PMCID: PMC7353956.

*Lodise TP, Tillotson GS, Spargo A, Bozkaya D, Massey J. The Role of Delafloxacin in Patients with Community-Acquired Bacterial Pneumonia in the Outpatient Setting: A Budget Impact Model. Clin Drug Investig. 2020 Oct;40(10):961-971. doi: 10.1007/s40261-020-00938-y. PMID: 32651832; PMCID: PMC7511275.

*Mercuro NJ, Lodise TP, Kenney RM, Rezik B, Vemulapalli RC, Costandi MJ, Davis SL. Impact of unit-specific metrics and prescribing tools on a family medicine ward. Infect Control Hosp Epidemiol. 2020 Jul 1:1-7. doi: 10.1017/ice.2020.288. Epub ahead of print. PMID: 32605686.

*Lodise TP, Colman S, Alexander E, Stein DS, Fitts D, Goldberg L, Schranz J. Health-Related Quality of Life as Measured by the 12-Item Short-Form Survey Among Adults With Community-Acquired Bacterial Pneumonia who Received Either Lefamulin or Moxifloxacin in 2 Phase III Randomized, Double-Blind, Double-Dummy Clinical Trials. Open Forum Infect Dis. 2020 Jun 3;7(6):ofaa209. doi: 10.1093/ofid/ofaa209. PMID: 32617376; PMCID: PMC7314585.

*Estrada S, Lodise TP, Tillotson GS, Delaportas D. The Real-World Economic and Clinical Management of Adult Patients with Skin and Soft Tissue Infections (SSTIs) with Oritavancin: Data from Two Multicenter Observational Cohort Studies. Drugs Real World Outcomes. 2020 Jun;7(Suppl 1):6-12. doi: 10.1007/s40801-020-00199-3. PMID: 32588389; PMCID: PMC7334314.

*Whittaker C, Lodise TP, Nhan E, Reilly J. Expediting Discharge in Hospitalized, Adult Patients with Skin and Soft Tissue Infections Who Received Empiric Vancomycin Therapy with Oritavancin: Description of Findings from an Institutional Pathway. Drugs Real World Outcomes. 2020 Jun;7(Suppl 1):30-35. doi: 10.1007/s40801-020-00196-6. PMID: 32588388; PMCID: PMC7334310.

*Helton B, MacWhinnie A, Minor SB, Lodise TP, Rafferty KD, Allison SL. Early Directed Oritavancin Therapy in the Emergency Department May Lead to Hospital Avoidance Compared to Standard Treatment for Acute Bacterial Skin and Skin Structure Infections: A Real-World Retrospective Analysis. Drugs Real World Outcomes. 2020 Jun;7(Suppl 1):20-29. doi: 10.1007/s40801-020-00201-y. PMID: 32588384; PMCID: PMC7334327.

*Lodise TP, Smith NM, O'Donnell N, Eakin AE, Holden PN, Boissonneault KR, Zhou J, Tao X, Bulitta JB, Fowler VG, Chambers HF, Bonomo RA, Tsuji BT. Determining the optimal dosing of a novel combination regimen of ceftazidime/avibactam with aztreonam against NDM-1-producing Enterobacteriaceae using a hollow-fibre infection model. J Antimicrob Chemother. 2020 May 28:dkaa197. doi: 10.1093/jac/dkaa197. Epub ahead of print. PMID: 32464664.

*Lodise T, Colman S, Stein DS, Fitts D, Goldberg L, Alexander E, Scoble PJ, Schranz J. Post Hoc Assessment of Time to Clinical Response Among Adults Hospitalized with Community-Acquired Bacterial Pneumonia Who Received Either Lefamulin or Moxifloxacin in 2 Phase III Randomized, Double-Blind, Double-Dummy Clinical Trials. Open Forum Infect Dis. 2020 Apr 24;7(5):ofaa145. doi: 10.1093/ofid/ofaa145. PMID: 32462049; PMCID: PMC7240345.

*Noviello S, Corey GR, Holland TL, Lodise T, O'Riordan W, Wilcox MH, File TM, Dryden M, Balser B, Scaramucci A, Torres A, Huang DB. A pooled analysis of patients with wound infections in the Phase 3 REVIVE trials: randomized, double-blind studies to evaluate the safety and efficacy of iclaprim versus vancomycin for treatment of acute bacterial skin and skin structure infections. J Med Microbiol. 2020 Mar 20. doi: 10.1099/jmm.0.001177. [Epub ahead of print] PubMed PMID: 32195649.

*Tillotson G, Lodise T, Classi P, Mildvan D, McKinnell JA. Antibiotic Treatment Failure and Associated Outcomes Among Adult Patients With Community-Acquired Pneumonia in the Outpatient Setting: A Real-world US Insurance Claims Database Study. Open Forum Infect Dis. 2020 Feb 26;7(3):ofaa065. doi: 10.1093/ofid/ofaa065. eCollection 2020 Mar. PubMed PMID: 32195289; PubMed Central PMCID: PMC7075486.

*Maskarinec SA, Park LP, Ruffin F, Turner NA, Patel N, Eichenberger EM, van Duin D, Lodise T, Fowler VG Jr, Thaden JT. Positive follow-up blood cultures identify high mortality risk among patients with Gram-negative bacteraemia. Clin Microbiol Infect. 2020 Feb 28. pii: S1198-743X(20)30050-1. doi: 10.1016/j.cmi.2020.01.025. [Epub ahead of print] PubMed PMID: 32114010

*Pais GM, Liu J, Avedissian SN, Hiner D, Xanthos T, Chalkias A, d'Aloja E, Locci E, Gilchrist A, Prozialeck WC, Rhodes NJ, Lodise TP, Fitzgerald JC, Downes  KJ, Zuppa AF, Scheetz MH. Lack of synergistic nephrotoxicity between vancomycin and piperacillin/tazobactam in a rat model and a confirmatory cellular model. J Antimicrob Chemother. 2020 May 1;75(5):1228-1236. doi: 10.1093/jac/dkz563. PubMed PMID: 32011685.

*Kullar R, Puzniak LA, Swindle JP, Lodise T. Retrospective Real-World Evaluation of Outcomes in Patients with Skin and Soft Structure Infections Treated with Tedizolid in an Outpatient Setting. Infect Dis Ther. 2020 Mar;9(1):107-117. doi: 10.1007/s40121-019-00279-0. Epub 2020 Jan 23. PubMed PMID: 31974828; PubMed Central PMCID: PMC7054470.

*Ferry T, Lodise TP, Gallagher JC, Forestier E, Goutelle S, Tam VH, Mohr JF 3rd, Roubaud-Baudron C. Outpatient Subcutaneous Antimicrobial Therapy (OSCAT) as a Measure to Improve the Quality and Efficiency of Healthcare Delivery for Patients With Serious Bacterial Infections. Front Med (Lausanne). 2020 Dec 23;7:585658. doi: 10.3389/fmed.2020.585658. PMID: 33425938; PMCID: PMC7785854.

*Lodise TP, Hall RG 2nd, Scheetz MH. Vancomycin Area Under the Curve-guided Dosing and Monitoring: "Is the Juice Worth the Squeeze"? Pharmacotherapy. 2020 Dec;40(12):1176-1179. doi: 10.1002/phar.2482. PMID: 33368454.

*Bidell MR, Pai MAP, Lodise TP. Use of Oral Tetracyclines in the Treatment of Adult Patients with Community-Acquired Bacterial Pneumonia: A Literature Review on the Often-Overlooked Antibiotic Class. Antibiotics (Basel). 2020 Dec 14;9(12):905. doi: 10.3390/antibiotics9120905. PMID: 33327437; PMCID: PMC7764829.

*Rybak MJ, Le J, Lodise TP, Levine DP, Bradley JS, Liu C, Mueller BA, Pai MP, Beringer AW, Rodvold KA, Maples HD. Questions on Vancomycin dosing. Clin Infect Dis. 2020 Nov 26:ciaa1775. doi: 10.1093/cid/ciaa1775. Epub ahead of print. PMID: 33238295.

*O'Donnell JN, Bidell MR, Lodise TP. Approach to the Treatment of Patients with Serious Multidrug-Resistant Pseudomonas aeruginosa Infections. Pharmacotherapy. 2020 Jul 21. doi: 10.1002/phar.2449. Epub ahead of print. PMID: 32696452.

*Morrisette T, Lodise TP, Scheetz MH, Goswami S, Pogue JM, Rybak MJ. The Pharmacokinetic and Pharmacodynamic Properties of Hydroxychloroquine and Dose Selection for COVID-19: Putting the Cart Before the Horse. Infect Dis Ther. 2020 Sep;9(3):561-572. doi: 10.1007/s40121-020-00325-2. Epub 2020 Aug 1. PMID: 32740858; PMCID: PMC7395206.

*Lodise TP, Rybak MJ. COVID-19: Important Therapy Considerations and Approaches in this Hour of Need. Pharmacotherapy. 2020 Apr 8. doi: 10.1002/phar.2396. [Epub ahead of print] PubMed PMID: 32267556.

*Rybak MJ, Le J, Lodise TP, Levine DP, Bradley JS, Liu C, Mueller BA, Pai MP, Wong-Beringer A, Rotschafer JC, Rodvold KA, Maples HD, Lomaestro BM. Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2020 Mar 19. pii: zxaa036. doi: 10.1093/ajhp/zxaa036. [Epub ahead of print] PubMed PMID: 32191793.

Jang SM, Parker WM, Pai AB, Jiang R, Cardone KE. Assessment of literacy and numeracy skills related to medication labels in patients on chronic in-center hemodialysis. J Am Pharm Assoc (2003). 2020 Nov-Dec;60(6):957-962.e1. Aug 16.

Cardone KE, Parker WM. Medication management in dialysis: Barriers and strategies. Semin Dial 2020 Nov;33(6):449-456. doi: 10.1111/sdi.12935. Epub 2020 Nov 19. PMID: 33210373

Codd C, Martinusen D, Cardone KE, Cho K, Pai AB. Preparing for implementation of a medication reconciliation measure for dialysis: Expanding the role of pharmacy technicians. Am J Health Syst Pharm. 2020;77(11):892-896.

Cardone KE. Nephrology. In: Review and Recertification Book for Board Certification in Ambulatory Care Pharmacy. American College of Clinical Pharmacy and American Society of Health-System Pharmacy, 2020.

Seo SW, Ombengi D, Sultan D, et al. An ethics-based approach to global health research, part 1: building partnerships in global health. Res Social Adm Pharm. 2020 Publication ahead of print

Drame I, Kahaleh A, Connor S, Seo SW, et al. An ethics-based approach to global health research, part 3: Emphasis on partnership funding. Res Social Adm Pharm. 2020 Publication ahead of print Amid COVID-19 Crisis, Pain Therapeutics Telehealth Services by Pharmacist Clinicians Fills Unique Void and Mitigates Risk https://journals.sagepub.com/doi/full/10.1177/2399202620947035

Briceland LL, Brewer JM, Dominelli A.  The Impact of Pharmacy Student Participation in the White Coat Ceremony on Professionalization.  American Journal of Pharmaceutical Education 2020, 84 (3) 7689; DOI: https://www.ajpe.org/content/84/3

Briceland LL, Brewer JM, Dominelli A.  Analysis of P1 student reflections to document impact of White Coat Ceremony participation on professionalization.  American Journal of Pharmaceutical Education. In press. https://www.ajpe.org/content/early/2020/01/29/ajpe7689    Publication ahead of print.

Lodise NM. Vaginal and Vulvovaginal Disorders. In: Krinsky DL, Ferreri SP, Hemstreet BA, Hume AL, Newton GD, Rollins CJ, Tietze KJ, editors. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care. 20th edition. Washington DC: American Pharmacists Association. 2020.

REGIONAL

Kiser SN, Peterson C, Steers R, Bach K. Rural Pharmacy Practice Offers Professional Satisfaction with Rewarding Patient Relationships. Pharmacy Society of Wisconsin-The Journal. 2020:55-58.

OUTSIDE SERVICE

• Jacqueline  Cleary was granted membership of the Clinical Pharmacogenomics Implementation Consortium (CPIC), 2020.
• Amanda Engle was named Chair-Elect for the ACCP Pain and Palliative Care PRN, 2020
• Amanda Engle has been elected to President-Elect for the New York State American College of Clinical Pharmacy, 2020
• Sandra Rosa has been elected president of the Vermont Pharmacists Association, 2020
• Lauren Bode has been elected first vice president of the Vermont Pharmacists Association, 2020
• Amy Yanicak has been elected second vice president of the Vermont Pharmacists Association, 2020
• Kelly Bach has been named President-Elect for the Northeastern Chapter of the NYSCHP Board, 2020
• Alexandra Watson has been named Treasurer for the Northeastern Chapter of the NYSCHP Board, 2020
• Courtney Caimano was appointed to the Institutional Review Board for St. Peter’s Health Partners, 2020
• Jessica Farrell has been nominated to the National Scleroderma Foundation Medical Advisory Board, 2020
• Michael Brodeur has been appointed as a Faculty Member for Project ECHO (Extension for Community Healthcare Outcomes) Maine Quality Counts Maine Medical Education Trust. Supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant number D06RH31043 Rural Health Network Development Program, 2020
• Gina Garrison has been invited, and agreed to serve, as one of 12 faculty nationwide who will serve on the Invited 2019-20 Mission Critical Task Force for The Rho Chi Society.

GRANTS

Jacqueline Cleary has been awarded  a $42,000 to develop a pharmacogenomic certificate program through the college by Genomind, is a pharmacogenomic testing company!  Jackie Mahoney was a big help and we are going to be using various ACPHS faculty members from different departments as well as some topic experts in the field, 2020.

Cardone KE (PI). Pharmacists’ use of mobile health technology in improving hypertension and cholesterol. NY State Department of Health, Contract, Funded ($49,999) September 2020 – September 2021.

Cardone KE (PI). Blood pressure monitor loaner and education program. NY State Department of Health, Contract ($23,000) June 2019 – June 2020.

Cardone KE (PI), Parker WM, Hitt R, McLaughlin C. The SCRIPT study: A Culturally-Sensitive Interactive Response Program to Promote Blood Pressure Control. The Hortense and Louis Rubin Community Health Fund of the Community Foundation for the Greater Capital Region. July 1 2019 – June 30, 2020 ($115,192; $88,609 Direct, $26,583 Indirect)

Amy Yanicak is the AACP 2020 Scholarship of Teaching and Learning Grant Recipient (May 2020)

Lodise TP A phase 1 study in healthy young adults to evaluate the safety and pharmacokinetics of AVYCAZ in combination with AZTREONAM (combine). Funding source: National Institute of Allergy & Infectious diseases. Funding mechanism: 1UM1AI104681-06. Performance dates: 12/01/2018-11/30/2021. Amount at ACPHS: $210,000 (varies by year). Role: Principal Investigator

Lodise TP PK ARLG Steering Committee Chair. Funding source: National Institute of Allergy & Infectious Diseases. Funding mechanism: 1UM1AI104681-01. Amount at ACPHS: $142,358 (varies by year). Performance dates: 12/01/15-11/30/21. Role: Chair. Principal Investigator: Vance Fowler, M.D.

Lodise TP An open-label Parmacokinetic study of minocycline for injection following a single infusion in critically-ill adults (Acumin). Funding source: National Institute of Allergy & Infectious Diseases. Funding mechanism: 1UM1AI104681-01. Amount at ACPHS: $142,851.07. Performance dates: 12/01/15-11/30/20. Role: Co-Investigator Principal Investigator: Richard Wunderlink, M.D.

Lodise TP Developing Suboxone treatment service to treat opioid use disorder. Funding source: NYS Office of Addiction Services & Supports (OASAS). Amount: $8,905. Performance dates: 4/19/2019-9/2020. Role: Pharmacist consultant. Percent effort: 4%.

2018 Scholarly activity report

The activities listed below are by members of the Department of Pharmacy Practice and span the period from January 1, 2018 - December 31, 2018.

* - ACPHS students denoted in bold.

Publications

Monique Bidell

• Bidell MR, Patel N, O'Donnell JN. Optimal treatment of MSSA bacteraemias: a meta-analysis of cefazolin versus antistaphylococcal penicillins. Journal of Antimicrobial Chemotherapy 2018 Oct 1;73(10):2643-2651. doi: 10.1093/jac/dky259.

Laurie Briceland

• Briceland LL, Rosa SW, Jablanski C, Lubowski TJ. Creation of Experiential Education Honors to Replace Dean's List in Recognizing Students for Exemplary Experiential Achievement. Journal of the American College of Clinical Pharmacy 2018;1–5. https://doi.org/10.1002/jac5.1019.

Michael Brodeur

• Pruyn S, Frey J, Baker B, Brodeur MR, Long H, Graichen C, Dailey M, Zheng H. Quality Assessment of Expired Naloxone Products from First-Responders' Supplies. Prehospital Emergency Care 2018;:1-7. 

Katie Cardone

• Denvir PM, Cardone KE, Parker WM, Cerulli J. How do I say that?: Using communication principles to enhance medication therapy management instruction. Currents in Pharmacy Teaching and Learning 2018;10:185-94.
• Kessler C, Cardone KE. Managing Comorbid Conditions in ESRD: Diabetes, Hypertension and Cardiovascular Conditions (Module 2). In: Pharmacotherapy for Patients on Dialysis, Davita and National Kidney Foundation, 2018.
• Cardone KE. Nephrology. In: Review and Recertification Book for Board Certification in Ambulatory Care Pharmacy, American College of Clinical Pharmacy, 2018.
• Cardone KE. Chronic Kidney Disease Medication Therapy Management Data Set (Chapter 16). In: Medication Therapy Management: A Comprehensive Approach, 2nd ed, Angaran DM, Whalen K, eds., McGraw-Hill, 2018. 

Jacqueline Cleary

• Prashad N, Cleary J. Galcanezumab: A New Calcitonin Gene-Related Peptide for Treating Migraine. Pharmacy Times, November 14, 2018.
• Turtoro J, Hennig K, Cleary J, Fudin J. Looking for UDM Guidelines? Guest blog article, PainDr.com, March 23, 2018.
• Fudin J, Cleary J, Sparkes S. Opioid Analgesics. In Pain Management Secrets, Argoff C et. al., ed., Chapter 38, Pg. 210-218, Fourth Ed. Elsevier Inc., 2018.

Clayton English

• English CD. New therapeutic options for the management of ADHD. US Pharmacist 2018;43(5):1-10
• English CD. Pharmacologic management of cluster headache. US Pharmacist 2018;43(1):1-10.
• DiSciullo AA, English CD, Horn WT. Modafinil Induced Psychosis in a Patient with Bipolar 1 Depression. Case Reports in Psychiatry 2018;2018:3.

Jessica Farrell

• Farrell JF. Selected Topics in Rheumatology: Core Therapeutic Module Series. American Society of Health-System Pharmacists (ASHP) Board Certified Pharmacotherapy Specialist (BCPS)/ Board Certified Ambulatory Care Pharmacist (BCACP) Review and Recertification program. 2018.

Nicole Lodise

• Griffin BL, Stone R, El-Ibiary S, Westberg S, Shealy K, Forinash A, Yancy A, Vest K, Karaoui L, Rafie S, Horlen C, Lodise NM, Cieri- Hutcherson N, McBane S, Simonyan A. Guide for Drug Selection During Pregnancy and Lactation: What Pharmacists Need to Know for Current Practice. Annals of Pharmacotherapy 2018.
• Murphy JE, Liles AM, Bingham AL, Chamberlin KW, Dang DK, Hill LG, Lee M, Leonard A, Lodise NM, Rogers E. Interprofessional education: Principles and application. An update from the American College of Clinical Pharmacy. Journal of the American College of Clinical Pharmacy 2018.

Thomas Lodise

• Bonine NG, Berger A, Altincatal A, Wang R, Bhagnani T, Gillard P, Lodise T. Impact of Delayed Appropriate Antibiotic Therapy on Patient Outcomes by Antibiotic Resistance Status From Serious Gram-negative Bacterial Infections. The American Journal of the Medical Sciences 2019 Feb;357(2):103-110. doi: 10.1016/j.amjms.2018.11.009. Epub 2018 Nov 22. PubMed PMID: 30665490.
• Tartof SY, Kuntz JL, Chen LH, Wei R, Puzniak L, Tian Y, Im TM, Takhar HS, Merchant S, Lodise T. Development and Assessment of Risk Scores for Carbapenem and Extensive β-Lactam Resistance Among Adult Hospitalized Patients With Pseudomonas aeruginosa Infection. JAMA Network Open 2018 Oct 5;1(6):e183927. doi: 10.1001/jamanetworkopen.2018.3927. PubMed PMID: 30646267; PubMed Central PMCID: PMC6324445.
• Hardalo C, Lodise TP, De Anda C. Myelosuppression with Oxazolidinones: Are There Differences? Antimicrobial Agents and Chemotherapy 2018 Dec 21;63(1). pii: e01833-18. doi: 10.1128/AAC.01833-18. Print 2019 Jan. PubMed PMID: 30578404.
• Rank EL, Lodise T, Avery L, Bankert E, Dobson E, Dumyati G, Hassett S, Keller M, Pearsall M, Lubowski T, Carreno JJ. Antimicrobial Susceptibility Trends Observed in Urinary Pathogens Obtained From New York State. Open Forum Infectious Diseases 2018 Nov 16;5(11):ofy297. doi: 10.1093/ofid/ofy297. eCollection 2018 Nov. PubMed PMID: 30539040; PubMed Central PMCID: PMC6284462.
• Lodise TP, Zhao Q, Fahrbach K, Gillard PJ, Martin A. A systematic review of the association between delayed appropriate therapy and mortality among patients hospitalized with infections due to Klebsiella pneumoniae or Escherichia coli: how long is too long? BMC Infect Diseases 2018 Dec 5;18(1):625. doi: 10.1186/s12879-018-3524-8. PubMed PMID: 30518337; PubMed Central PMCID: PMC6280436.
• Bland CM, Pai MP, Lodise TP. Reappraisal of Contemporary Pharmacokinetic and Pharmacodynamic Principles for Informing Aminoglycoside Dosing. Pharmacotherapy. 2018 Dec;38(12):1229-1238. doi: 10.1002/phar.2193. PubMed PMID: 30403305.
• Lodise T, Corey R, Hooper D, Cammarata S. Safety of Delafloxacin: Focus on Adverse Events of Special Interest. Open Forum Infectious Diseases. 2018 Sep 10;5(10):ofy220. doi: 10.1093/ofid/ofy220. eCollection 2018 Oct. PubMed PMID: 30349845; PubMed Central PMCID: PMC6189306.
• Bidell MR, Lodise TP. Suboptimal Clinical Response Rates with Newer Antibiotics Among Patients with Moderate Renal Impairment: Review of the Literature and Potential Pharmacokinetic and Pharmacodynamic Considerations for Observed Findings. Pharmacotherapy. 2018 Dec;38(12):1205-1215. doi: 10.1002/phar.2184. Epub 2018 Nov 9. PubMed PMID: 30289995.
• Crass RL, Pai MP, Lodise TP Jr. Individualizing piperacillin/tazobactam dosing in adult patients with cystic fibrosis: can tobramycin measurements help? Journal of Antimicrobial Chemotherapy 2019 Jan 1;74(1):126-129. doi: 10.1093/jac/dky388. PubMed PMID: 30252050.
• Patel N, Huang D, Lodise T. Potential for Cost Saving with Iclaprim Owing to Avoidance of Vancomycin-Associated Acute Kidney Injury in Hospitalized Patients with Acute Bacterial Skin and Skin Structure Infections. Clinical Drug Investigation 2018 Oct;38(10):935-943. doi: 10.1007/s40261-018-0686-5. PubMed PMID: 30105549.
• Martin A, Fahrbach K, Zhao Q, Lodise T. Association Between Carbapenem Resistance and Mortality Among Adult, Hospitalized Patients With Serious Infections Due to Enterobacteriaceae: Results of a Systematic Literature Review and Meta-analysis. Open Forum Infectious Diseases 2018 Jun 28;5(7):ofy150. doi: 10.1093/ofid/ofy150. eCollection 2018 Jul. Review. PubMed PMID: 30046639; PubMed Central PMCID: PMC6054228. 
• Zasowski EJ, Lodise TP. The Importance of Individualized Vancomycin Dosing to Ensure Optimal Exposure Early in Therapy. The Journal of Clinical Pharmacology 2018 Sep;58(9):1131-1133. doi: 10.1002/jcph.1281. Epub 2018 Jul 19. PubMed PMID: 30024648.
• Butterfield-Cowper JM, Lodise TP Jr, Pai MP. A Fixed versus Weight-Based Dosing Strategy of Daptomycin May Improve Safety in Obese Adults. Pharmacotherapy 2018 Sep;38(9):981-985. doi: 10.1002/phar.2157. Epub 2018 July 12. PubMed PMID: 29906315.
• Huang DB, Corey GR, Holland TL, Lodise T, O'Riordan W, Wilcox MH, File TM Jr, Dryden M, Balser B, Desplats E, Torres A. Pooled analysis of the phase 3 REVIVE trials: randomised, double-blind studies to evaluate the safety and efficacy of iclaprim versus vancomycin for treatment of acute bacterial skin and skin-structure infections. International Journal of Antimicrobial Agents 2018 Aug;52(2):233-240. doi: 10.1016/j.ijantimicag.2018.05.012. Epub 2018 May 19. PubMed PMID: 29783024.
• Holland TL, O'Riordan W, McManus A, Shin E, Borghei A, File TM Jr, Wilcox MH, Torres A, Dryden M, Lodise T, Oguri T, Corey GR, McLeroth P, Shukla R, Huang DB. A Phase 3, Randomized, Double-Blind, Multicenter Study To Evaluate the Safety and Efficacy of Intravenous Iclaprim versus Vancomycin for Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed To Be Due to Gram-Positive Pathogens (REVIVE-2 Study). Antimicrobial Agents and Chemotherapy 2018 Apr 26;62(5). pii: e02580-17. doi: 10.1128/AAC.02580-17. Print 2018 May. PubMed PMID: 29530858; PubMed Central PMCID: PMC5923167.
• Hardalo C, Lodise TP, Bidell M, Flanagan S, De Anda C, Anuskiewicz S, Prokocimer P. Clinical safety and tolerability of tedizolid phosphate in the treatment of acute bacterial skin and skin structure infections. Expert Opinion on Drug Safety 2018 Apr;17(4):359-367. doi: 10.1080/14740338.2018.1446939. Epub 2018 Mar 12. Review. PubMed PMID: 29528251.
• McKinnell JA, Corman S, Patel D, Leung GH, Gordon LM, Lodise TP. Effective Antimicrobial Stewardship Strategies for Cost-effective Utilization of Telavancin for the Treatment of Patients With Hospital-acquired Bacterial Pneumonia Caused by Staphylococcus aureus. Clinical Therapeutics 2018 Mar;40(3):406-414.e2. doi: 10.1016/j.clinthera.2018.01.010. Epub 2018 Feb 15. PubMed PMID: 29454592.
• Lodise TP, Bosso J, Kelly C, Williams PJ, Lane JR, Huang DB. Pharmacokinetic and Pharmacodynamic Analyses To Determine the Optimal Fixed Dosing Regimen of Iclaprim for Treatment of Patients with Serious Infections Caused by Gram-Positive Pathogens. Antimicrobial Agents and Chemotherapy 2018 Jan 25;62(2). pii: e01184-17. doi: 10.1128/AAC.01184-17. Print 2018 Feb. PubMed PMID: 29133566; PubMed Central PMCID: PMC5786772.
• Luther MK, Timbrook TT, Caffrey AR, Dosa D, Lodise TP, LaPlante KL. Vancomycin Plus Piperacillin-Tazobactam and Acute Kidney Injury in Adults: A Systematic Review and Meta-Analysis. Critical Care Medicine 2018 Jan;46(1):12-20. doi: 10.1097/CCM.0000000000002769. Review. PubMed PMID: 29088001.
• Lodise TP, Bidell M. Time to Evolve: Addressing the Challenge of CRE. Medscape https://www.medscape.org/viewarticle/894178.

Nick O’Donnell

• Bidell MR, Patel N, O'Donnell JN. Optimal treatment of MSSA bacteraemias: a meta-analysis of cefazolin versus antistaphylococcal penicillins. Journal of Antimicrobial Chemotherapy 2018 Oct 1;73(10):2643-2651. doi: 10.1093/jac/dky259.
• Wang SK, Gilchrist A, Loukitcheva A, Plotkin BJ, Sigar IM, Gross AE, O'Donnell JN, Pettit N, Buros A, O'Driscoll T, Rhodes NJ, Bethel C, Segreti J, Charnot-Katsikas A, Singh K, Scheetz MH. Prevalence of a Cefazolin Inoculum Effect Associated with blaZ Gene Types among Methicillin-Susceptible Staphylococcus aureus Isolates from Four Major Medical Centers in Chicago. Antimicrobial Agents and Chemotherapy 2018 Jul 27;62(8). pii: e00382-18. doi: 10.1128/AAC.00382-18.
• O'Donnell JN, Rhodes NJ, Lopez J, Jett R, Scheetz MH. Carbapenems vs. alternative β-lactams for the treatment of nosocomial pneumonia: A systematic review and meta-analysis. International Journal of Antimicrobial Agents 2018 Oct;52(4):451-458. doi: 10.1016/j.ijantimicag.2018.04.011.
• Rhodes NJ, Cruce CE, O'Donnell JN, Wunderink RG, Hauser AR. Resistance Trends and Treatment Options in Gram-Negative Ventilator-Associated Pneumonia. Current Infectious Disease Reports 2018 Mar 6;20(2):3. doi: 10.1007/s11908-018-0609.
• Crew PE, Rhodes NJ, O'Donnell JN, Miglis C, Gilbert EM, Zembower TR, Qi C, Silkaitis C, Sutton SH, Scheetz MH. Correlation between hospital-level antibiotic consumption and incident health care facility-onset Clostridium difficile infection. American Journal of Infection Control 2018 Mar;46(3):270-275. doi: 10.1016/j.ajic.2017.09.015.
• Rhodes NJ, Liu J, O'Donnell JN, Dulhunty JM, Abdul-Aziz MH, Berko PY, Nadler B, Lipman J, Roberts JA. Prolonged Infusion Piperacillin-Tazobactam Decreases Mortality and Improves Outcomes in Severely Ill Patients: Results of a Systematic Review and Meta-Analysis. Critical Care Medicine 2018 Feb;46(2):236-243. doi: 10.1097/CCM.0000000000002836.

Alexandra Watson

• Braungart C, Watson A, Rubin R. The effects of interprofessional collaboration on Nurse Managed Warfarin Program. Journal of Interprofessional Education and Practice, September 2018.

CONFERENCES AND PRESENTATIONS

Kelly Bach

• Bach K, Hopsicker A, St. John T, Morgan F, Bassi S. Proton pump inhibitors utilization and hospital acquired Clostridium difficile infections in a community teaching hospital.  American Society of Health-System Pharmacists Midyear Clinical Meeting, Anaheim CA, December 2018.
• Bach K, Hopsicker A, St. John T, Morgan F, Bassi S. Proton pump inhibitors utilization and hospital acquired Clostridium difficile infections in a community teaching hospital. Ellis Medicine Nursing Day of Inquiry, Schenectady NY, November 2018.

Monique Bidell

• Bidell MR, Novak G, Singh G, Bratek B, Duru O, Mitchell C, O’Donnell JN. A multicenter Evaluation of Outcomes Associated With Oral Vancomycin Dose in Patients With Clostridium difficile Infection. IDWeek 2018, San Francisco CA, October 2018.
• Caimano CR, Smith AJ, Bidell MR. Assessing Medication Name Pronunciation on Introductory Pharmacy Practice Experiences. AACP Annual Meeting, Boston MA, July 21-23, 2018.
• Garrison GD, Bidell M, Cabral K, Silvestro L, Boire A, Strang AF. Interdisciplinary Formative Assessments to Foster Student Learning in the Dual-Campus Large Classroom Setting (School Poster). AACP Annual Meeting, Boston MA, July 21-23, 2018.

Abby Boire

• Garrison GD, Bidell M, Cabral K, Silvestro L, Boire A, Strang AF. Interdisciplinary Formative Assessments to Foster Student Learning in the Dual-Campus Large Classroom Setting (School Poster). AACP Annual Meeting, Boston MA, July 21-23, 2018.

Jane Boyd

• Kane T, Boyd J, Obos L, Meek P. Raising the Bar for Student Performance in a 6-semester Pharmacy Skills Sequence. AACP Annual Meeting, Boston MA, July 21-23, 2018. 

Michael Brodeur

• Brodeur MR. Update in Geriatric Pharmacotherapy: A Focus on Deprescribing. Explore Aging Conference, SUNY Plattsburgh/University of Vermont Health Network. October 9, 2018.
• Frey J, Pruyn S, Brodeur MR, Baker B, Long H, Graichen C, Dailey M, Zheng H. Meeting the demand for naloxone: stability of expired naloxone solution. North American Congress of Clinical Toxicology (NACCT), Chicago IL, October 25-29, 2018 (platform presentation).
• Frey J, Pruyn S, Brodeur MR, Baker B, Long H, Graichen C, Dailey M, Zheng H. Quality Assessment of Expired Naloxone Products from First-Responders’ Supplies. American Association of Colleges of Pharmacy (AACP) annual meeting, Boston MA, July 21, 2018 (poster).

Jeffrey Brewer

• Strang AF, Briceland LL, Garrison GD, Kane TH, Brewer JM, Seo SW. Are Students Practicing Self-awareness? An Inventory of Critical Reflection Throughout the Curriculum/Co-Curriculum. AACP Annual Meeting, Boston MA, July 21-23, 2018.
• Briceland LL, Brewer JM, Dominelli AC. An Analysis of P1 Student Reflections on the Impact of White Coat Ceremony Participation. AACP Annual Meeting, Boston MA, July 21-23, 2018.

Laurie Briceland

• Strang AF, Briceland LL, Garrison GD, Kane TH, Brewer JM, Seo SW. Are Students Practicing Self-awareness? An Inventory of Critical Reflection Throughout the Curriculum/Co-Curriculum. AACP Annual Meeting, Boston MA, July 21-23, 2018.
• Briceland LL, Brewer JM, Dominelli AC. An Analysis of P1 Student Reflections on the Impact of White Coat Ceremony Participation. AACP Annual Meeting, Boston MA, July 21-23, 2018.
• Briceland LL, Caimano CR, Rosa SW, Jablanski C, Veselov M. Creation of Experiential Success Plan Initiative to Address Experiential Performance Deficiencies. AACP Annual Meeting, Boston MA, July 21-23, 2018. 

Kate Cabral

• Garrison GD, Bidell M, Cabral K, Silvestro L, Boire A, Strang AF. Interdisciplinary Formative Assessments to Foster Student Learning in the Dual-Campus Large Classroom Setting (School Poster). AACP Annual Meeting, Boston MA, July 21-23, 2018.
• Decina L, Parsels K, Cabral K. The Implementation of Pharmacy Consult Services in Lipid Management with Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors. NYS American College of Clinical Pharmacy Meeting, November 2, 2018.

Courtney Caimano

• Caimano CR, Veselov M, Kane TH, Rosa SW. Student Specific Remediation Plans for Introductory Pharmacy Practice Experiences. AACP Annual Meeting, Boston MA, July 21-23, 2018.
• Caimano CR, Smith AJ, Bidell MR. Assessing Medication Name Pronunciation on Introductory Pharmacy Practice Experiences. AACP Annual Meeting, Boston MA, July 21-23, 2018.
• Briceland LL, Caimano CR, Rosa SW, Jablanski C, Veselov M. Creation of Experiential Success Plan Initiative to Address Experiential Performance Deficiencies. AACP Annual Meeting, Boston MA, July 21-23, 2018. 

Katie Cardone

• Cardone KE. Opioid use in patients with end-stage renal disease. Centers for Medicare & Medicaid Services, Learning and Action Network call, May 2018. 
• Cardone KE. Foundations of Nutrition Practice for kidney disease: Nephrology Pharmacology. National Kidney Foundation 2018 Spring Clinical Meeting, Austin TX, April 2018. 
• Cardone KE. Diabetes and Beyond: SGLT2 Inhibitors, the other medication. National Kidney Foundation 2018 Spring Clinical Meeting, Austin TX, April 2018.  
• Cardone KE. Tailoring Antibiotic Regimens for distinct RRT modalities: it’s not just about the dose: Automated Peritoneal Dialysis. National Kidney Foundation 2018 Spring Clinical Meeting, Austin TX, April 2018.  
• Cardone KE. Nephrology Review for the Ambulatory Care Pharmacist; Review and recertification course for board certified ambulatory care pharmacists (BCACP). American College of Clinical Pharmacy 2018 Spring Conference, Jacksonville FL, February 2018.
• Gawdat M, Parker W, Johnsen A, Baumeister T, Cardone KE. Medicare part D coverage of phosphate binders. American Society of Health-System Pharmacy 2018 Midyear Clinical Meeting, Anaheim CA, December 2018.
• Cardone KE, Grabe DG, Michaud-Sachs M. Would you or wouldn't you? Using script concordance-style questions to enhance clinical reasoning and online discussion. Online Learning Consortium Accelerate Conference, Orlando FL, November 2018.
• Sangiovanni RJ, Stornelli N, Yager JL, Lodise TP, Cardone KE, Patel N. Incidence and predictors of subsequent vancomycin-associated acute kidney injury (VA-AKI) in Veterans’ Affairs patients who have previously experienced VA-AKI. National Kidney Foundation 2018 Spring Clinical Meeting, Austin TX, April 2018.
• Cardone KE. Delivering Medication Therapy Management Services, 4th ed. Certificate training program and continuing education for pharmacists, Albany College of Pharmacy and Health Sciences, Albany NY, December 2018.
• Cardone KE. Novel approaches to hyperkalemia management. Mohawk Valley Pharmacists Association, Utica NY, September 2018.
• Cardone KE. What’s new with Diabetes? Mohawk Valley Pharmacists Association, Utica NY, September 2018.

Joseph Carreno

• Vitale G, Eaton R, Laquidara A, Mitchell C, Carreno J. Inpatient antimicrobial stewardship medication use evaluation of meropenem at Albany Medical Center Hospital. ASHP Midyear Clinical Meeting, Anaheim CA, December 2-6, 2018.

Jacqueline Cleary

• Gawdat M, Gawdat M, Bettinger J, Cleary J, Fudin F. Analysis of Variable Morphine Milligram Equivalent (MME) Threshold Trends by State. ASHP, Anaheim CA, December 2018.
• Higgins O, Cleary J. Pharmacy Driven Naloxone Distribution in Patients with High Risk for Opioid-Induced Respiratory Depression. NYS ACCP Annual Meeting, Cooperstown NY, November 2018.
• Higgins O, Cleary J. Pharmacy Driven Naloxone Distribution in Patients with High Risk for Opioid-Induced Respiratory Depression. ACPHS Student Summer Research Day, Albany NY, October 2018.
• Bettinger J, Cleary J, Fudin J, Wegrzyn E. False-positive 6-mono acetyl morphine (6-MAM) Saliva Test Result in a Patient Taking Morphine and Aspirin: A Case Report. Pain Week, Las Vegas NV, September 2018.
• Cleary J, Joyce A, Zedler B, Thomson H, Gudin J. Risk Factors for Prescription Opioid Overdose: Is It All Substance Use Disorder? ICOO, Boston MA June 2018.
• Mansour V, Chauhan C, Clark L, Cleary J. Pharmacist Driven Naloxone Distribution in a Federally Qualified Health Center through Risk Index. ICOO, Boston MA, June 2018.
• Cleary J, Joyce A, Zedler B, Thomson H, Gudin J. Risk Factors for Prescription Opioid Overdose: Is It All Substance Use Disorder? AAPM, Vancouver Canada, April 2018.  
• Mansour V, Chauhan C, Clark L, Cleary J. Pharmacist Driven Naloxone Distribution in a Federally Qualified Health Center through Risk Index. International Conference on Opioids (ICOO), Boston MA, June 2018.

Angela Dominelli

• Briceland LL, Brewer JM, Dominelli AC. An Analysis of P1 Student Reflections on the Impact of White Coat Ceremony Participation. AACP Annual Meeting, Boston MA, July 21-23, 2018.
• Gicewicz E, Steffey M, Stornelli N, Armeli J, Perko N, Kile D, Dominelli AC. The Grove Independent Pharmacy Business Plan: Good Neighbor Pharmacy NCPA Pruitt-Schutte Student Business Plan Competition Top 10 finalist Poster Presentation. National Community Pharmacists Association Annual Conference, Boston MA, October 2018.

Amanda Engle

• Engle A. Buprenorphine: Clinical Pearls for Safe and Effective Use. The Nurse Practitioner Association of New York 34th Annual Conference, Saratoga Springs NY, October 2018 (invited presentation).
• Engle A. Buprenorphine: Clinical Pearls for Safe and Effective Use. Pain and Hospice and Palliative Care Symposium. Albany College of Pharmacy and Health Sciences, Albany NY, October 2018 (invited presentation).
• Engle A, Winans A. Implementation of an automated naloxone co-prescribing program within a large rural health care network.  Atlantic Pain Coalition- NYS IPRO Pain Management Task Force.  August 2018. (invited presentation)
• Engle A, Winans A. Implementation of an automated naloxone co-prescribing program within a large rural health care network. NYS Pharmacy Conference, September 2018, (invited presentation).
• Monzyk J, Pluckrose D, Nguyen S, Desemone J, Engle A. Interprofessional Student Collaboration: Benefits of Medical and Pharmacy Students Working Together on an Interprofessional Acute Care Rounding Team. ASHP Midyear Clinical Meeting, Anaheim CA, December 2-6, 2018.
• Pluckrose D, Engle A, Maceira E. 4-Factor prothrombin complex concentrate dose capping as a strategy for management of drug shortage. ASHP Midyear Clinical Meeting, Anaheim CA, December 2-6, 2018.
• Shtoyko A, Stornelli N, Jacob J, Wayne J, Engle A. Making the PIPE dream a reality: a pharmacy-medical student collaborative practice model. ASHP Midyear Clinical Meeting, Anaheim CA, December 2-6, 2018.    

Clayton English

• English CD. Long-Acting Injectable Antipsychotics: A review of New Injectables for maintenance treatment of schizophrenia. Vermont-Society of Health Systems Pharmacist Annual CE Program, Montpelier VT, November 2018 (invited presentation).
• English CD. Headaches: Updates on Abortive and Prophylactic Treatments for Migraine & Cluster Headache. Albany College of Pharmacy and Health Sciences, Colchester VT, October 2018 (invited presentation).
• English CD. Major Depressive Disorder: Updates in Pharmacological Management. Albany College of Pharmacy and Health Sciences, Colchester VT, September 2018 (invited presentation).
• English CD. Moving Beyond Opioids: Non-Controlled Pharmaceuticals for the Management of Chronic Pain. Integrative Pain Management Conference, University of Vermont, Burlington VT, April 2018 (invited presentation).

Jessica Farrell

• Farrell JF. Selected Topics in Rheumatology: Core Therapeutic Module Series. Presented to board certified pharmacists, an ACPE-accredited 1-hour CE webinar program as part of American Society of Health-System Pharmacists (ASHP) Ambulatory Care and Pharmacotherapy Pharmacy Specialty Review Course. 2018. 
• Farrell JF. Overcoming Challenges in Juvenile Idiopathic Arthritis: Advances in Treatment & Management. Presented to health professionals, an ACPE-accredited 2-hour CE webinar program as part of Specialty Pharma Education Center Continuing Education Program. 2018.
• Farrell JF. Multiple Perspectives in the Treatment of Systemic Lupus Erythematosus (SLE). 11th Annual Rheumatology Nurses Society Conference, Fort Worth TX, August 10, 2018. 
• Farrell JF. Medical Information Toolkit:  How to Find Reliable Medical Information on the Internet. Scleroderma Foundation National Patient Education Conference, Philadelphia PA, July 29, 2018.
• Farrell JF. Scleroderma Disease and Medication Related Questions: Parent and Kids Q&A. Scleroderma Foundation National Patient Education Conference, Philadelphia PA, July 29, 2018.
• Farrell JF. Biosimilars: Incorporating Use into Practice and Clinical Implications for Pharmacists. Presented to pharmacists, an ACPE-accredited CE program at the 2018 Spring IDN Summit and Reverse Expo, Orlando FL, April 17, 2018. 
• Farrell JF, Coblyn JS, Griffin F. Monotherapy for Rheumatoid Arthritis: Leveraging the Latest Evidence to Treat-to-Target. An ACPE-accredited CE webinar program as part of Clinical Care Options Immunology Continuing Education Program. 2018. 
• Farrell JF, Saag K. Optimal Approaches to Gout. An ACPE-accredited CE webinar program as part of Haymarket Medical Education Continuing Education Program. 2018. 
• Farrell JF. Safety Considerations for the Use of Anti-inflammatory and Disease Modifying Therapies in Autoimmune and Inflammatory Disorders. Presented to pharmacists, an ACPE-accredited 1-hour CE program as part of American Health Resources Continuing Education Program, Albany NY, May 3, 2018. 
• Farrell JF, Banerjee S. Large Vessel Vasculitis. Presented to physicians, pharmacists, health-care providers, residents and students at St. Peter’s Hospital Main Grand Rounds.  Albany NY, February 14, 2018.

Andy Flynn

• Flynn A, McConchie L. ReCAPS(S) of the 2018 Legislative Session - What Made It, What Didn’t, What’s Next. Capital Area Pharmacists Society Annual Meet and Greet, Latham NY, September 12, 2018.

Gina Garrison

• Garrison GD. Impact of Student Critical Reflection on Learning Habits using Exam Performance Reports. ExamSoft Assessment Conference 2018, Fort Lauderdale FL (1 hr live).
• Strang AF, Briceland LL, Garrison GD, Kane TH, Brewer JM, Seo SW. Are Students Practicing Self-awareness? An Inventory of Critical Reflection Throughout the Curriculum/Co-Curriculum. AACP Annual Meeting, Boston MA, July 21-23, 2018.
• Garrison GD, Strang AF. A Novel Process for Guiding Student Critical Reflection on Learning Habits Through Exam Performance Analysis. AACP Annual Meeting, Boston MA, July 21-23, 2018.
• Garrison GD, Bidell M, Cabral K, Silvestro L, Boire A, Strang AF. Interdisciplinary Formative Assessments to Foster Student Learning in the Dual-Campus Large Classroom Setting (School Poster). AACP Annual Meeting, Boston MA, July 21-23, 2018.

Darren Grabe

• Cardone KE, Grabe DG, Michaud-Sachs M. Would you or wouldn't you? Using script concordance-style questions to enhance clinical reasoning and online discussion. Online Learning Consortium Accelerate Conference, Orlando FL, November 2018.

Elizabeth Higdon

• Higdon E. Doctorate of Pharmacy. Presented to college students in the Intro to Health Professions course. SUNY Plattsburgh, Plattsburgh NY, November 2018.
• Higdon E. Cocos Nucifera and Ascorbic Acid Compounding Workshop. Presented to high school students at admissions event. Colchester VT, November 2018.

Teresa Kane

• Kane TH, Boyd J, Obos L, Meek P. Raising the Bar for Student Performance in a 6-semester Pharmacy Skills Sequence. AACP Annual Meeting, Boston MA, July 21-23, 2018.
• Caimano CR, Veselov M, Kane TH, Rosa SW. Student Specific Remediation Plans for Introductory Pharmacy Practice Experiences. AACP Annual Meeting, Boston MA, July 21-23, 2018.
• Strang AF, Briceland LL, Garrison GD, Kane TH, Brewer JM, Seo SW. Are Students Practicing Self-awareness? An Inventory of Critical Reflection Throughout the Curriculum/Co-Curriculum. AACP Annual Meeting, Boston MA, July 21-23, 2018.

David Kile

• Gicewicz E, Steffey M, Stornelli N, Armeli J, Perko N, Kile D, Dominelli A. The Grove Independent Pharmacy Business Plan: Good Neighbor Pharmacy NCPA Pruitt-Schutte Student Business Plan Competition Top 10 finalist Poster Presentation. National Community Pharmacists Association Annual Conference, Boston MA, October 2018.

Nicole Lodise

• Hudmon K, Lodise NM, Allard I, Vis G, Pohl H, Frenz H, Vitale F, Corelli R. A Hybrid Learning Approach for Tobacco Cessation Counseling Training. American Association of Colleges of Pharmacy (AACP) Annual Meeting, Boston MA, July 2018. (Poster Presentation).

Thomas Lodise

• LaPensee K, Lodise T. Cost-savings Analysis with Use of Omadacycline Among Hospitalized Community-Acquired Pneumonia Patients At Risk of Clostridium difficile Infection Being Treated with Moxifloxacin: Budget Impact Model Findings. ASHP Midyear Clinical Meeting, Anaheim CA, December 2-6, 2018. Poster #4-049. Presenter: LaPensee.
• LaPensee K, Lodise T. Cost-saving Opportunities Among Hospitalized Community-Acquired Pneumonia Patients Treated with Omadacycline, an Aminomethylcycline Antibiotic with IV and Oral Formulations, Compared to Ceftriaxone and Macrolide Therapy. ASHP Midyear Clinical Meeting, Anaheim CA, December 2-6, 2018. Poster #4-048. Presenter: LaPensee.
• Lodise T, LaPensee K. Hospital Admission Patterns in Adult Patients with Community-acquired Bacterial Pneumonia who Received Ceftriaxone and a Macrolide by Pneumonia Severity Index Score. IDweek2018, San Francisco CA, October 3-7, 2018. Abstract #1462. Presenter: Lodise.
• Patel N, Clark J, Stornelli N, Belfiore G, Lodise TP. Comparative Evaluation of Adverse Tendon Events between Recipients of Fluoroquinolones and Ceftriaxone/Azithromycin among Veterans Affairs Patients with Community Acquired Bacterial Pneumonia. IDweek2018, San Francisco CA, October 3-7, 2018. Abstract #1463. Presenter: Patel.
• Puzniak L, Fu R, Gundrum J, Lodise TP. Real World Evaluation of Patient Characteristics and Outcomes of Patients Treated with Ceftolozane/Tazobactam across 253 US hospitals. IDweek2018, San Francisco CA, October 3-7, 2018. Abstract # 2414. Presenter: Lodise.
• Lodise T, Packnett E, Armstrong S, Redell M. Comparisons of 30-Day Admission and 30-Day Total Healthcare Costs Between Patients Who Were Treated With Oritavancin (ORI) or Vancomycin (VAN) for a Skin Infection in the Outpatient Setting. IDweek2018, San Francisco CA, October 3-7, 2018. Abstract # 1928. Presenter: Lodise.
• Lodise TP, Bonine NG, Ye JM, Folse HJ, Gillard P. Development of a Bedside Tool to Predict the Probability of Drug-Resistant Pathogens among an Adult Population with Gram-Negative Infections. IDweek2018, San Francisco CA, October 3-7, 2018. Abstract # 1166. Presenter: Lodise.
• Saade E, Wilson B, El Chakhtoura NG, Viau R, Perez F, Lodise T, Bonomo RA. Drug-Induced Liver Injury (DILI) in a National Cohort of Hospitalized Patients treated with Aztreonam and Ceftazidime. IDweek2018, San Francisco CA, October 3-7, 2018. Abstract # 2409. Presenter: Saade.
• Cai B, Echols R, Corvino R, Lodise TP. Epidemiology and Outcomes of Patients with Carbapenem-Resistant Bloodstream Infection in United States (US) Hospitals, 2010-2015. IDweek2018, San Francisco CA, October 3-7, 2018. Abstract # 681. Presenter: Echols.
• Lodise TP, Smith NM, Holden P, O'Donnell JN, Bedard T, Bonomo RA, Tsuji BT. Efficacy of Ceftazidime-Avibactam in Combination with Aztreonam (COMBINE): Solutions for Metallo-β-lactamase producing-Enterobacteriaceae (MBL). IDweek2018, San Francisco CA, October 3-7, 2018. Abstract # 1385. Presenter: Tsuji.
• Avedissian S, Liu J, O'Donnell JN, Pais G, Becher L, Joshi M, Prozialeck W, Lamar P, Lodise TP, Scheetz MH. Poster presentation at IDweek2018™. San Francisco, CA. October 3-7, 2018. Abstract # 1419. Presenter: Avedissian.
• Rank E, Lodise TP, Avery L, Bankert E, Dobson E, Dumyati G, Hassett S, Keller M, Lubowski T, Pearsall M, Carreno J. New York State Outpatient Regional Antibiogram for Urinary Pathogens: Have We Reached a Post Antibiotic Era for the Treatment of UTIs? IDweek2018, San Francisco CA, October 3-7, 2018. Abstract # 1237. Presenter: Carreno.
• Huang D, Corey RG, Holland TL, Lodise TP, O'Rirodan W, Wilcox M, File TM, Dryden M, Torres A, Balser B, Desplats E. A Pooled Analysis of Patients with Wound Infections in the Phase 3 REVIVE Trials: Randomized, Double-blind Studies to EValuate the Safety and Efficacy of Iclaprim Versus Vancomycin for trEatment of Acute Bacterial Skin and Skin Structure Infections. IDweek2018, San Francisco CA, October 3-7, 2018. Abstract # 1338. Presenter: Huang.
• Shorr A, Lodise T, Echols R, Wang W, Corvino FA, B. Cai B, Zilberberg M. Prevalence and Microbiology of Carbapenem Resistance Among Six Gram-Negative Pathogens in Bloodstream Infections in US Hospitals, 2010-2015. IDweek2018, San Francisco CA, October 3-7, 2018. Abstract # 1191. Presenter: Echols.
• Patel N, Sangiovanni R, Stornelli N, Amin R, Huang D, Lodise TP. Frequency of vancomycin-associated acute kidney injury and healthcare utilization among Veterans' Affairs patients with skin and skin structure infections. 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Madrid Spain, April 21-24, 2018. ePoster viewing #E0283. Presenter: Patel.
• Tartof S, Kuntz J, Chen L, Wei R, Puzniak L, Tian Y, Im T, Takhar H, Merchan S, Lodise TP. A clinical risk score to predict the likelihood of carbapenem non-susceptible and pan-beta-lactam non-susceptibility among adult, hospitalized patients with infections due to Pseudomonas aeruginosa. 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Madrid Spain, April 21-24, 2018. Oral flash #O0130. Presenter: Lodise.
• Patel N, Huang D, Lodise T. Potential cost savings opportunities with targeted iclaprim (ICL) compared to vancomycin (VAN) among hospitalized patients with acute bacterial skin and skin structure infectious due to potential avoidance of VAN-associated acute kidney injury. 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Madrid Spain, April 21-24, 2018. Paper poster #P0283. Presenter: Patel.
• Crass R, Lodise T, Pai M. Individualizing piperacillin/tazobactam dosing in adult patients with cystic fibrosis: can tobramycin measurements help? 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Madrid Spain, April 21-24, 2018. Paper poster #P0868. Presenter: Crass.

Patrick Meek

• Kane T, Boyd J, Obos L, Meek P. Raising the Bar for Student Performance in a 6-semester Pharmacy Skills Sequence. AACP Annual Meeting, Boston MA, July 21-23, 2018.  

Lee Anna Obos

• Kane T, Boyd J, Obos L, Meek P. Raising the Bar for Student Performance in a 6-semester Pharmacy Skills Sequence. AACP Annual Meeting, Boston MA, July 21-23, 2018.  

Nick O’Donnell

• Bidell MR, Novak G, Singh G, Bratek B, Duru O, Mitchell C, O’Donnell JN. A multicenter Evaluation of Outcomes Associated With Oral Vancomycin Dose in Patients With Clostridium difficile Infection. IDWeek 2018, San Francisco CA, October 2018.
• Lodise TP, Smith NM, Holden P, O’Donnell JN, Bedard T, Bonomo RA, Tsuji BT. Efficacy of Ceftazidime–Avibactam in Combination with Aztreonam (COMBINE): Solutions for Metallo-β-Lactamase Producing-Enterobacteriaceae (MBL). IDWeek 2018, San Francisco CA, October 2018.
• Avedissian S, Liu J, O’Donnell JN, Pais G, Becher L, Joshi M, Prozialeck W, Lamar P, Lodise TP, Scheetz MH. 24-Hour Pharmacokinetic Relationships for Intravenous Vancomycin and Novel Urinary Biomarkers of Acute Kidney Injury. IDWeek 2018, San Francisco CA, October 2018.

Sandra Rosa

• Caimano CR, Veselov M, Kane TH, Rosa SW. Student Specific Remediation Plans for Introductory Pharmacy Practice Experiences. AACP Annual Meeting, Boston MA, July 21-23, 2018.
• Briceland LL, Caimano CR, Rosa SW, Jablanski C, Veselov M. Creation of Experiential Success Plan Initiative to Address Experiential Performance Deficiencies. AACP Annual Meeting, Boston MA, July 21-23, 2018. 

See-Won Seo

• Strang AF, Briceland LL, Garrison GD, Kane TH, Brewer JM, Seo SW. Are Students Practicing Self-awareness? An Inventory of Critical Reflection Throughout the Curriculum/Co-Curriculum. AACP Annual Meeting, Boston MA, July 21-23, 2018.
• Kahaleh A, Law M, Seo SW, Tofade T. Crosswalk between the ACPE Standards and the FIP Nanjing Outcomes. AACP Annual Meeting, Boston MA, July 21-23, 2018.
• Seo SW, Kahaleh A, Law M, Tofade T. Use of the FIP Nanjing Statements to compare national pharmacy education standards in the USA. Poster presented at: International Pharmaceutical Federation World Congress, Glasgow Scotland, September 2018.
• Seo SW. Delivering Medication Therapy Management Services, 4th ed. Certificate training program and continuing education for pharmacists, Albany College of Pharmacy and Health Sciences, Albany NY, December 2018.  
• Seo SW. Dyslipidemia: Updates In Management. Mohawk Valley Pharmacists Association, Utica NY, September 2018.
• Seo SW. Updates in Hypertension Management. Mohawk Valley Pharmacists Association, Utica NY, September 2018.

Alyssa Smith

• Caimano CR, Smith AJ, Bidell MR. Assessing Medication Name Pronunciation on Introductory Pharmacy Practice Experiences. AACP Annual Meeting, Boston MA, July 21-23, 2018.

Matthew Stryker

• Farina K, Stryker M. Altered thyroid function tests (TFTs) and unnecessary thioamide therapy following treatment with high-dose biotin (300mg). ASHP Midyear Clinical Meeting, Anaheim CA, December 2-6, 2018.

Megan Veselov

• Caimano CR, Veselov M, Kane TH, Rosa SW. Student Specific Remediation Plans for Introductory Pharmacy Practice Experiences. AACP Annual Meeting, Boston MA, July 21-23, 2018.
• Briceland LL, Caimano CR, Rosa SW, Jablanski C, Veselov M. Creation of Experiential Success Plan Initiative to Address Experiential Performance Deficiencies. AACP Annual Meeting, Boston MA, July 21-23, 2018. 

Alexandra Watson

• Wilson L, Myrka A, Watson A, Guay, K. Meeting the MIPS Challenge: A Conversation about Strategies to Address the Opioid Crisis. IPRO, October 2018 (webinar).
• Wilson L, Myrka A, Watson A. Meeting the MIPS Challenge: A Conversation about Anticoagulant Management Best Practices. IPRO, April 2018 (webinar).
• Watson A. The Latest in Hypertension and Lipid Management. Continuing Pharmacy Education, ACPHS, Albany NY, June 2018.
• Watson A, Guay K, Ribis D. Warfarin Management Training. CapitalCare Medical Group Nursing Council, January 2018.

Matthew Yacobucci

• Ubowski MM, VanSice RP, Yacobucci M, Chablani L. Microparticulate Cancer Vaccines: Evaluation of a Novel Immunotherapeutic Approach. American Society of Health-System Pharmacists Midyear Clinical Meeting, Anaheim CA, December 2018.

Amy Yanicak

• Yanicak A. Medical student and resident perceptions of ambulatory pharmacy before and after one year of interprofessional collaboration in an adult medicine evening clinic. ACCP Global Conference, Seattle WA, October 20-23, 2018.

EXTRAMURAL GRANTS 

Jessica Farrell 
Awarded a $45,000 grant for residency funding on behalf of and through the Center for Rheumatology by Janssen Biotech.

Thomas Lodise
Role: Principal Investigator
Project Title: A Phase 1 Study In Healthy Young Adults To Evaluate The Safety And Pharmacokinetics Of AVYCAZ® In Combination With Aztreonam (COMBINE)
Grantor: Sub-award through Duke University; Primary sponsor: National Institute of Allergy and Infectious Diseases
Amount at ACPHS: $90,000
Grant Number: 1UM1AI104681-06
Term: 11/01/2018 – 12/31/2018

Role: Co-Investigator (PI: Richard Wunderlink, MD)
Project Title: An Open-Label Pharmacokinetic Study of Minocycline for Injection Following a Single Infusion in Critically-Ill Adults (Acumin)
Grantor: Sub-award through Duke University; Primary sponsor: National Institute of Allergy and Infectious Diseases
Grant Number: 1UM1AI104681-01 
Amount at ACPHS: $48,000
Term: 11/01/18 - 12/31/18

Role: Chair (PI: Vance Fowler, MD)
Project Title: PK ARLG Steering Committee Chair
Grantor: Sub-award through Duke University; Primary sponsor: National Institute of Allergy and Infectious Diseases
Grant Number: 1UM1AI104681-01 
Amount at ACPHS: $342,000
Term: 1/01/18- 12/31/18 

HONORS, AWARDS, and APPOINTMENTS

BOARD CERTIFICATIONS

• Kelly Bach - Board Certified Geriatric Pharmacist. 
• Jeffrey Brewer - Board Certified Ambulatory Care Pharmacist (7-year renewal).
• Kate Cabral - Board Certified Cardiology Pharmacist.  
• Matthew Yacobucci - Board Certified Oncology Pharmacist. 

AWARDS and RECOGNITION

• Kate Cabral received the advanced designation in the American College of Cardiology as an “Associate” of the American College of Cardiology (AACC).  
• Jessica Farrell received the 2018 Ernest J. Dupont award at the Steffens Scleroderma Foundation Fundraiser on October 12, 2018.
• DRUGDEX Information Systems (Medicare recognized drug database) accepted Jessica Farrell’s application for systemic sclerosis (SSc) as an off-label indication within the mycophenolate mofetil (CellCept) drug monograph 2018.
• Gina Garrison and Aimee Strang received the Innovations in Teaching Award Honorable Mention from the American Association of Colleges of Pharmacy.   
• Nicole Lodise was recognized by the American College of Clinical Pharmacy (ACCP), for her outstanding work toward the 2016-2018 Ambulatory Care Self-Assessment Program, a home-study series for ambulatory care pharmacists.
• Joanna Schwatz and Ai Tran were awarded the 1st place poster at the 2018 Annual Meeting & Palliative Care Symposium. Poster title: “Potential herb-chemotherapy or radiation interactions in patients with cancer: A prospective study of the pharmacist and student-pharmacist run herbal assessment service at the University of Vermont (UVM) Cancer Center.”

APPOINTMENTS

• Kelly Bach was named President-Elect for the Northeastern Chapter of the NYS Council of Health-system Pharmacists Board. 
• Lauren Bode was appointed to the Board of Directors of the Vermont Pharmacists Association.
• Courtney Caimano was appointed to the Institutional Review Board for St. Peter’s Health Partners.
• Katie Cardone was named Nephrology section editor of “Pharmacotherapy First,” a multimedia learning resource from the American Pharmacists Association.
• Amanda Engle was named President-Elect of the NYS Chapter of the American College of Clinical Pharmacy.
• Jessica Farrell was nominated to the national Scleroderma Foundation Medical Advisory Board.
• Nicole Lodise was elected Chair of the American College of Clinical Pharmacy (ACCP) Women's Health PRN.
• See-Won Seo was:
  • Appointed Co-Chair for Community Education, Outreach, and Advocacy Work Group for the Asthma Coalition of the Capital Region (ACCR).
  • Appointed Assistant Pharmacy Director for World Health Ambassadors.
  • Re-appointed Communications and Collaborations Committee Co-Chair for the AACP Global Pharmacy Education Special Interest Group.
  • Appointed Public Policy Chair for the NYSCHP Public Policy Committee.
• Alexandra Watson was named Treasurer for the Northeastern Chapter of the NYS Council of Health-system Pharmacists Board.
• Amy Yanicak was appointed to the ACCP Ambulatory Care PRN Research Process Committee.

2017 Scholarly activity report

The activities listed below are by members of the Department of Pharmacy Practice and span the period from January 1, 2017 - December 31, 2017.

Publications 

Monique Bidell
Martirosov DM, Bidell MR, Pai MP, Scheetz MH, Rosenkranz SL, Faragon C, Malik M, Mendes RE, Jones RN, McNutt LA, Lodise TP. Relationship between day 1 and day 2 vancomycin area under the curve values and emergence of heterogeneous vancomycin-intermediate Staphylcoccus aureus (hVISA) by Etest® macromethod among patients with MRSA bloodstream infections: A pilot study. BMC Infect Dis 2017;17(1):534.

Martirosov DM, Bidell MR, Pai MP, Scheetz MH, Rosenkranz SL, Lodise TP. Relationship between vancomycin exposure and outcomes among patients with MRSA bloodstream infections with vancomycin Etest® MIC values of 1.5 mg/L: A pilot study. Diagn Microbiol Infect Dis 2017;88(3):259-63.

Bidell MR, Opraseuth MP, Yoon M, Mohr J, Lodise TP. Effect of prior receipt of antibiotics on the pathogen distribution and antibiotic resistance profile of  key Gram-negative pathogens among patients with hospital-onset urinary tract infections. BMC Infect Dis. 2017 Feb 28;17(1):176. doi: 10.1186/s12879-017-2270-7. PubMed PMID: 28241755; PubMed Central PMCID: PMC5329905.

Michael Brodeur
Persico A, Ngai K, Brodeur MR. Students' Perspectives on Nebulized Drugs and Nebulizer Maintenance. The Consultant Pharmacist. Consult Pharm. 2017 Sep 1;32(9):519-524. doi: 10.4140/TCP.n.2017.519.

Kate Cabral
*Padala SK, Lavelle MP, Sidhu MS, Cabral KP, Morrone D, Boden WE, Toth PP. Antianginal Therapy for Stable Ischemic Heart Disease: A Contemporary Review. J Card Pharm Ther Nov 2017;22(6):499-510.

Katie Cardone
Denvir PM, Cardone KE, Parker WM, Cerulli J. “How do I say that?”: Using communication principles to enhance medication therapy management instruction. Currents in Pharmacy Teaching and Learning, In press, October 2017.

Parker W, Donato K, Cardone KE, Cerulli J. Experiential education builds student self-confidence in delivering medication therapy management. Pharmacy 2017;5(3):E39.

Parker WM, Ferreira K, Vernon L, Cardone KE. The delicate balance of keeping it all together: Using social capital to manage multiple medications for patients on dialysis. Res Social Adm Pharm 2017;13(4):738-745.

St. Peter WL, Wazny LD, Weinhandl E, Cardone KE, Hudson JQ. Phosphate Binders in Chronic Kidney Disease: Incremental Progress or Just Higher Costs? Drugs 2017 Jul;77(11):1155-1186. 

Cardone KE. Nephrology. In: Review and Recertification Book for Board Certification in Ambulatory Care Pharmacy. American College of Clinical Pharmacy, 2017.

Joseph Carreno
Carreno JJ, Kenney RM, Divine G, Vazquez JA, Davis SL. Randomized Controlled Trial to Determine the Efficacy of Early Switch From Vancomycin to Vancomycin Alternatives as a Strategy to Prevent Nephrotoxicity in Patients With Multiple Risk Factors for Adverse Renal Outcomes (STOP-NT). Ann Pharmacother. 2017 Mar;51(3):185-193. doi: 10.1177/1060028016673858. Epub 2016 Nov 13.

McLaughlin M, Carreno JJ, Harpe SE, Jensen AO, Lomaestro B, Esterly JS. Multicenter evaluation of IV acyclovir use prior to, during, and after a national shortage. Infect Dis (Lond). 2017 Oct;49(10):778-780. doi: 10.1080/23744235.2017.1325002. Epub 2017 May 17. 

Carreno JJ, Lomaestro B, Tietjan J, Lodise TP. Evaluation of a Bayesian Approach to Estimate Vancomycin Exposure in Obese Patients with Limited Pharmacokinetic Sampling: A Pilot Study. Antimicrob Agents Chemother. 2017 Apr 24;61(5). pii: e02478-16. doi: 10.1128/AAC.02478-16. Print 2017 May.

Jacqueline Cleary
Cleary J, Watson A.  Review of Naloxone Products, Patient’s Candidacy, and Legislation for Pharmacists. NYS Pharmacist- Publication of PSSNY.  Vol 91 (4).  August 2017.

Cleary J, Brennan Michael, Fudin J.  Opioid rotation from Opana ER Following FDA Call for Removal.  Practical Pain Management 2017 July/August.  Available at: https://www.practicalpainmanagement.com/treatments/pharmacological/opioids/opioid-rotation-opana-er-following-fda-call-removal

Clayton English
English C, Muhleisen A, Rey JA. Flibanserin (Addyi®): The First FDA-Approved Treatment for Female Sexual Interest/Arousal Disorder in Premenopausal Women. P&T. 2017;42(4):237-241.

Elizabeth Higdon
Higdon ERB. “Test your Over-The-Counter Sunscreen Knowledge.” NYS Pharmacists Journal, vol. 91, no. 3, June 2017, pp. 14

Michael P. Kane
Stryker MD, Kane MP, Busch RS. A Real-World, Observational Study of Weekly Exenatide Added to Basal Insulin in Patients with Type 2 Diabetes Mellitus (NCT02895672). Endocrinol Diab Metab. 2017;00:e4. http://orcid.org/0000-0002-0648-6465. 

Busch RS, Kane MP. Combination SGLT2 inhibitor and GLP-1 receptor agonist therapy: a complementary approach to the treatment of type 2 diabetes. Postgraduate Medicine. 2017;129:686–697. DOI:10.1080/00325481.2017.1342509  

Kane MP. Endocrine Disorders. In: Bainbridge JL, Cardone K, Cross LB, et al. Updates in Therapeutics®: Ambulatory Care Pharmacy Preparatory Review and Recertification Course, 2017 ed. Lenexa, KS: American College of Clinical Pharmacy, 2017:1-262 - 1-322.

Nicole Lodise
Stone R, Rafie S, El-Ibiary S, Vernon V, Lodise NM.  Emergency Contraception Algorithm and Guide for Clinicians. Nurs Womens Health. 2017 Aug - Sep;21(4):297-305.

Thomas Lodise
O’Donnell JN, Rhodes NJ, Lodise TP. 24-Hour Pharmacokinetic Relationships for Vancomycin and Novel Urinary Biomarkers of Acute Kidney Injury.  Prozialeck WC, Miglis CM, Joshi M, Venkatesan N, Pais G, Cluff C, Lamar PC, Briyal S, Day JZ, Gulati A, Scheetz MH.  Antimicrob Agents Chemother. 2017 Aug 14

Carreno JJ, Lomaestro B, Tietjan J, Lodise TP. Evaluation of a Bayesian Approach to Estimate Vancomycin Exposure in Obese Patients with Limited Pharmacokinetic Sampling: A Pilot Study. Antimicrob Agents Chemother. 2017 Apr 24;61(5). pii: e02478-16. doi: 10.1128/AAC.02478-16. Print 2017 May.

Martirosov DM, Bidell MR, Pai MP, Scheetz MH, Rosenkranz SL, Faragon C, Malik M, Mendes RE, Jones RN, McNutt LA, Lodise TP. Relationship between day 1 and day 2 vancomycin area under the curve values and emergence of heterogeneous vancomycin-intermediate Staphylcoccus aureus (hVISA) by Etest® macromethod among patients with MRSA bloodstream infections: A pilot study. BMC Infect Dis 2017;17(1):534.

Martirosov DM, Bidell MR, Pai MP, Scheetz MH, Rosenkranz SL, Lodise TP. Relationship between vancomycin exposure and outcomes among patients with MRSA bloodstream infections with vancomycin Etest® MIC values of 1.5 mg/L: A pilot study. Diagn Microbiol Infect Dis 2017;88(3):259-63.

O'Donnell JN, Rhodes NJ, Lodise TP, Prozialeck WC, Miglis CM, Joshi MD, Venkatesan N, Pais G, Cluff C, Lamar PC, Briyal S, Day JZ, Gulati A, Scheetz MH. 24-Hour Pharmacokinetic Relationships for Vancomycin and Novel Urinary Biomarkers of Acute Kidney Injury. Antimicrob Agents Chemother. 2017 Oct 24;61(11). 

O’Donnell JN, Rodes NJ, Miglis CM, Catovic L, Liu J, Cluff C, Pais G, Avedissian S, Joshi M, Griffin B, Prozialeck W, Gulati A, Lodise TP, Scheetz MH.  Doses, durations, and gender predict vancomycin-induced kidney injury in pre-clinical studies. Int J Antimicrob Agents. 2017 Aug 10

McKinnell JA, Corman S, Patel D, Leung GH, Gordon LM, Lodise TP. Effective Antimicrobial Stewardship Strategies for Cost-Effective Utilization of Telavancin for the Treatment of Patients With Hospital-Acquired Bacterial Pneumonia Caused
by Staphylococcus aureus. Clin Ther. 2018 Feb 14. pii: S0149-2918(18)30012-2. doi: 10.1016/j.clinthera.2018.01.010. [Epub ahead of print] PubMed PMID:
29454592.

Lodise TP, Bosso J, Kelly C, Williams PJ, Lane JR, Huang DB. Pharmacokinetic and Pharmacodynamic Analyses To Determine the Optimal Fixed Dosing Regimen of Iclaprim for Treatment of Patients with Serious Infections Caused by
Gram-Positive Pathogens. Antimicrob Agents Chemother. 2018 Jan 25;62(2). pii: e01184-17. doi: 10.1128/AAC.01184-17. Print 2018 Feb. PubMed PMID: 29133566; PubMed Central PMCID: PMC5786772.

Natesan S, Pai MP, Lodise TP. Determination of alternative ceftolozane/tazobactam dosing regimens for patients with infections due to Pseudomonas aeruginosa with MIC values between 4 and 32 mg/L. J Antimicrob
Chemother. 2017 Oct 1;72(10):2813-2816. doi: 10.1093/jac/dkx221. PubMed PMID: 29091209.

Luther MK, Timbrook TT, Caffrey AR, Dosa D, Lodise TP, LaPlante KL. Vancomycin Plus Piperacillin-Tazobactam and Acute Kidney Injury in Adults: A Systematic Review and Meta-Analysis. Crit Care Med. 2018 Jan;46(1):12-20. doi:
10.1097/CCM.0000000000002769. Review. PubMed PMID: 29088001.

Lodise TP, Fan W, Griffith DC, Dudley MN, Sulham KA. A Retrospective Cohort Analysis Shows that Coadministration of Minocycline with Colistin in Critically Ill Patients Is Associated with Reduced Frequency of Acute Renal Failure.
Antimicrob Agents Chemother. 2017 Dec 21;62(1). pii: e01165-17. doi: 10.1128/AAC.01165-17. Print 2018 Jan. PubMed PMID: 29038261; PubMed Central PMCID: PMC5740356.

Lodise T, Ye MJ, Zhao Q. Prevalence of Invasive Infections Due to Carbapenem-Resistant Enterobacteriaceae among Adult Patients in U.S. Hospitals. Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: e00228-17. doi:
10.1128/AAC.00228-17. Print 2017 Aug. PubMed PMID: 28559271; PubMed Central PMCID: PMC5527580.

Lodise TP, Redell M, Armstrong SO, Sulham KA, Corey GR. Efficacy and Safety of Oritavancin Relative to Vancomycin for Patients with Acute Bacterial Skin and  Skin Structure Infections (ABSSSI) in the Outpatient Setting: Results From the SOLO Clinical Trials. Open Forum Infect Dis. 2017 Jan 19;4(1):ofw274. doi: 10.1093/ofid/ofw274. eCollection 2017 Winter. PubMed PMID: 28480266; PubMed Central PMCID: PMC5414048.

Martirosov DM, Bidell MR, Pai MP, Scheetz MH, Rosenkranz SL, Lodise TP. Relationship between vancomycin exposure and outcomes among patients with MRSA bloodstream infections with vancomycin Etest® MIC values of 1.5mg/L: A pilot
study. Diagn Microbiol Infect Dis. 2017 Jul;88(3):259-263. doi: 10.1016/j.diagmicrobio.2017.03.008. Epub 2017 Apr 2. PubMed PMID: 28449844; PubMed Central PMCID: PMC5512425.

Doernberg SB, Lodise TP, Thaden JT, Munita JM, Cosgrove SE, Arias CA, Boucher HW, Corey GR, Lowy FD, Murray B, Miller LG, Holland TL; Gram-Positive Committee of the Antibacterial Resistance Leadership Group (ARLG). Gram-Positive Bacterial 
Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group. Clin Infect Dis. 2017 Mar 15;64(suppl_1):S24-S29. doi: 10.1093/cid/ciw828. Review. PubMed PMID: 28350900.

Rhodes NJ, Prozialeck WC, Lodise TP, Venkatesan N, O'Donnell JN, Pais G, Cluff C, Lamar PC, Neely MN, Gulati A, Scheetz MH. Correction for Rhodes et al., Evaluation of Vancomycin Exposures Associated with Elevations in Novel Urinary
Biomarkers of Acute Kidney Injury in Vancomycin-Treated Rats. Antimicrob Agents Chemother. 2017 Mar 24;61(4). pii: e00185-17. doi: 10.1128/AAC.00185-17. Print 2017 Apr. PubMed PMID: 28341810; PubMed Central PMCID: PMC5365701.

Bidell MR, Opraseuth MP, Yoon M, Mohr J, Lodise TP. Effect of prior receipt of antibiotics on the pathogen distribution and antibiotic resistance profile of  key Gram-negative pathogens among patients with hospital-onset urinary tract
infections. BMC Infect Dis. 2017 Feb 28;17(1):176. doi: 10.1186/s12879-017-2270-7. PubMed PMID: 28241755; PubMed Central PMCID: PMC5329905.

J Nicholas O’Donnell
Crew PE, Rhodes NJ, O'Donnell JN, Miglis C, Gilbert EM, Zembower TR, Qi C, Silkaitis C, Sutton SH, Scheetz MH. Correlation between hospital-level antibiotic consumption and incident health care facility-onset Clostridium difficile infection. Am J Infect Control. 2017 Nov 21. pii: S0196-6553(17)31067-2. 

O'Donnell JN, Rhodes NJ, Lodise TP, Prozialeck WC, Miglis CM, Joshi MD, Venkatesan N, Pais G, Cluff C, Lamar PC, Briyal S, Day JZ, Gulati A, Scheetz MH. 24-Hour Pharmacokinetic Relationships for Vancomycin and Novel Urinary Biomarkers of Acute Kidney Injury. Antimicrob Agents Chemother. 2017 Oct 24;61(11). 

Rhodes NJ, Grove ME, Kiel PG, O’Donnell JN, Whited LK, Rose DT, Jones DR, Scheetz MH.  Population pharmacokinetics of cefepime of febrile neutropenia: implications for dose-dependent susceptibility and contemporary dosing regimens. Int J Antimicrob Agents 2017 Sept

O’Donnell JN, Rodes NJ, Miglis CM, Catovic L, Liu J, Cluff C, Pais G, Avedissian S, Joshi M, Griffin B, Prozialeck W, Gulati A, Lodise TP, Scheetz MH.  Doses, durations, and gender predict vancomycin-induced kidney injury in pre-clinical studies. Int J Antimicrob Agents. 2017 Aug 10

Joshi MD, O’Donnell JN, Vekatesan N, Chang J, Nguyen H, Rhodes NJ, Pais G, Champan RL, Griffin B, Scheetz MH. High-Performance Liquid Chomatography Method for Rich Pharmacokinetic Sampling Schemes in Translational Rat Toxicity Models with Vandomycin. Clin Transl Sci 2017 July 4

O'Donnell JN, Ghossein C, Rhodes NJ, Peng J, Lertharakul T, Pham CK, Scheetz MH. Eight unexpected cases of vancomycin associated acute kidney injury with contemporary dosing. J Infect Chemother. 2017 May;23(5):326-332. 

Rhodes NJ, Prozialeck WC, Lodise TP, Venkatesan N, O'Donnell JN, Pais G, Cluff C, Lamar PC, Neely MN, Gulati A, Scheetz MH. Correction for Rhodes et al., Evaluation of Vancomycin Exposures Associated with Elevations in Novel Urinary
Biomarkers of Acute Kidney Injury in Vancomycin-Treated Rats. Antimicrob Agents Chemother. 2017 Mar 24;61(4). pii: e00185-17. doi: 10.1128/AAC.00185-17. Print 2017 Apr. PubMed PMID: 28341810; PubMed Central PMCID: PMC5365701.

Nimish Patel
Yager J, Faragon J, McGuey L, Hoye-Simek A, Hecox Z, Sullivan S, Neubert S, Patel N. Relationship between Single Tablet Antiretroviral Regimen and Adherence to Antiretroviral and Non-Antiretroviral Medications among Veterans’ Affairs Patients with Human Immunodeficiency Virus. AIDS Patient Care STDS. 2017 Sep;31(9):370-376. doi: 10.1089/apc.2017.0081. Epub 2017 Aug 3.

Britt NS, Potter EM, McKinnell JA, Patel N, Battersby SE, Steed ME. Secular trends in nosocomial vancomycin-resistant enterococcal bloodstream infections among United States Veterans Affairs hospitals, fiscal years 2004-2014. Infect Control Hosp Epidemiol. 2017 Jul 11:1-3. doi: 10.1017/ice.2017.125. [Epub ahead of print].

Malek W, Yager J, Britt NS, Morse C, Hecox Z, Hoye-Simek A, Sullivan S, Patel N. Clinical Outcomes Associated with Single Tablet Regimens: Relationship between Antiretroviral Therapy Pill Burden and Control of Concomitant Comorbidities among HIV-infected Patients. Journal of HIV and Retrovirus. 2017 June;3(1:5):1–7.

Jakeman B, Nasiri M, Ruth L, Morse C, Mahatme S, Patel N. Comparing the Frequencies of Contraindicated Drug-Drug Interactions Between Differing Antiretroviral Regimens in HIV-Infected Patients. Ann Pharmacother. 2017 May;51(5):365-372. doi: 10.1177/1060028016685115. Epub 2016 Dec 20.

Britt NS, Potter EM, Patel N, Steed ME. Effect of Continuous and Sequential Therapy Among Veterans Receiving Daptomycin or Linezolid for Vancomycin-Resistant Enterococcus faecium Bacteremia. Antimicrob Agents Chemother. 2017 Apr 24;61(5). pii: e02216-16. doi: 10.1128/AAC.02216-16. Print 2017 May.

Britt NS, Potter EM, Patel N, Steed ME. Comparative Effectiveness and Safety of Standard-, Medium-, and High-Dose Daptomycin Strategies for the Treatment of Vancomycin-Resistant Enterococcal Bacteremia Among Veterans Affairs Patients. Clin Infect Dis. 2017 Mar 1;64(5):605-613. doi: 10.1093/cid/ciw815.

Matthew Stryker
Stryker MD, Kane MP, Busch RS. A Real-World, Observational Study of Weekly Exenatide Added to Basal Insulin in Patients with Type 2 Diabetes Mellitus (NCT02895672). Endocrinol Diab Metab. 2017;00:e4. http://orcid.org/0000-0002-0648-6465. 

Alexandra Watson
Cleary J, Watson A. Review of Naloxone Products, Patient Candidacy, and Legislation for Pharmacists. NYS Pharmacist. August 2017.

Book chapters 

Katie Cardone
Cardone KE. Chronic Kidney Disease Medication Therapy Management Data Set (Chapter 16). In: Angaran DM, Whalen K, eds. Medication Therapy Management: A Comprehensive Approach, 2nd ed. McGraw-Hill, 2017. 

Joseph Carreno
Carreno JJ, Martirosov D, Lodise TP. “Current Approach to Optimal Use and Dosing of Vancomycin in Adult Patients,” In: LaPlante K, Cunha C, Morrill H, Rice L, Mylonakis E, eds. Antimicrobial Stewardship Principles and Practice. 1st ed. Boston: CAB International; 2017. p 235 – 254. 

Jacqueline Cleary
Fudin, Cleary J, Kominek, Brooks. ASAM Handbook on Pain and Addiction.  Section II. Diagnosing and Treating Pain and Addiction: General Principles.  Chapter 9.  Pham. 2017.

Thomas Lodise
Carreno JJ, Martirosov D, Lodise TP. “Current Approach to Optimal Use and Dosing of Vancomycin in Adult Patients,” In: LaPlante K, Cunha C, Morrill H, Rice L, Mylonakis E, eds. Antimicrobial Stewardship Principles and Practice. 1st ed. Boston: CAB International; 2017. p 235 – 254. 

Poster Presentations 

Kelly Bach
Bach K. Prevention and Treatment of Herpes Zoster.  ACPE Accredited CE Presentation.  Albany College of Pharmacy and Health Sciences, May 2017.

Monique Bidell
O’Donnell JN, MR Bidell, N Patel. Optimal Treatment Of Methicillin-sensitive Staphylococcus Aureus (MSSA) Blood Stream Infections: A Meta-analysis Of Cefazolin Versus Antistaphylococcal Penicillins. Poster Presentation. 2nd annual ASM Microbe. New Orleans, LA. June 2017

Bidell, M, Cabral K. Why complete a pharmacy residency & how to prepare to be a competitive candidate. ACPHS/NYSCHP Residency Preparation Symposium, ACPHS, Albany, NY. October 2017.

Bidell, M. Infectious Diseases Potpourri. Albany Family Practice Medical Resident Lecture Series. Albany, NY. September 2017.

Bidell, M, Watson A. Appropriate use of antibiotics: Upper respiratory infections. Continuing Medical Education. Webinar, Albany, NY. August 2017.

Jeffrey Brewer
Briceland LL, Strang AF, Jablanski C, Caimano C, Rosa, Kane TS, Brewer JM; Scarpace Peters S. PhIT (Pharmacist-in-Training): An Electronic Portfolio to Document Students’ Personal and Professional Development;  2017 AACP Annual Meeting, Nashville, TN, July 16, 2017.

Sidhu MS, Costello K, Strang AF, Brewer JM, Kilby KA, Brodeur M. Inter-Professional Education via Geriatrics Focused 1-Day Program. Association of American Medical Colleges Northeast Group on Educational Affairs (NEGEA) Annual Conference, Rochester, NY, May 2017

Laurie Briceland
Briceland LL, Strang AF, Jablanski C, Caimano C, Rosa, Kane TS, Brewer JM; Scarpace Peters S. PhIT (Pharmacist-in-Training): An Electronic Portfolio to Document Students’ Personal and Professional Development;  2017 AACP Annual Meeting, Nashville, TN, July 16, 2017.

Rosa S, Briceland LL.  Using APhA Career Pathway Evaluation Program to Aid students in Choosing APPE Rotations and Beyond;  2017 AACP Annual Meeting, Nashville, TN, July 16, 2017.

Strang A, Briceland LL, Garrison G, Hamilton RA. Student Reflections on Impact of APPE Learning; School Poster 2017 AACP Annual Meeting, Nashville, TN, July 15, 2017.

Michael Brodeur
Davenport C, Meek PD, Nubla J, Nissen J,  Wolff M, Brodeur MR, Institution Specific Antibiograms: Tailoring Antibiotic Stewardship for Nursing Homes. Poster A98. American Society of Consultant Pharmacists, November 2017, Nashville Tennessee.

Davenport C, Meek PD, Nubla J, Nissen J,  Wolff M, Brodeur MR, Institution Specific Antibiograms: Tailoring Antibiotic Stewardship for Nursing Homes. Poster A98. American Geriatrics Society, May 2017, San Antonio, TX.

Sidhu MS, Costello K, Strang AF, Brewer JM, Kilby KA, Brodeur M. Inter-Professional Education via Geriatrics Focused 1-Day Program. Association of American Medical Colleges Northeast Group on Educational Affairs (NEGEA) Annual Conference, Rochester, NY, May 2017

Courtney Caimano
Briceland LL, Strang AF, Jablanski C, Caimano C, Rosa, Kane TS, Brewer JM, Scarpace Peters S. PhIT (Pharmacist-in-Training): An Electronic Portfolio to Document Students’ Personal and Professional Development; 2017 AACP Annual Meeting, Nashville, TN, July 16, 2017.

Kate Cabral
Bidell, M, Cabral K. Why complete a pharmacy residency & how to prepare to be a competitive candidate. ACPHS/NYSCHP Residency Preparation Symposium, ACPHS, Albany, NY. October 2017.

Katie Cardone
Karn M, Cardone KE, Daoui R, Daoui S, Parker WM. Navigating Complex Patient Care with Social Support: Lessons learned from patients with chronic kidney disease. Submitted to: 10th Annual Conference on the Science of Dissemination and Implementation (D&I) in Health, Academy Health; December 2017; Arlington, VA.

Cardone KE, Seo S. Delivering Medication Therapy Management in the Community, American Pharmacist’s Association Certificate training program and continuing education for pharmacists. Albany College of Pharmacy and Health Sciences, Albany, NY; October 2017. 

Davis JM, Cleary JH, Cardone KE. Assessment of opioid-induced adverse event risk in patients on hemodialysis. American College of Clinical Pharmacy 2017 Virtual Poster Symposium; 2017 May, virtual. 

Davis JM, Parker WM, Donato KM, Daoui S, Daoui R, Cardone KE. Medication management strategies among patients with chronic kidney disease (CKD). National Kidney Foundation 2017 Spring Clinical Meeting; 2017 April; Orlando, FL.

Joseph Carreno
Sangiovanni RJ, Yager J, Carreno JJ, O’Donnell JN, Lowry C, Carlyn C, Patel N. Retreatment with Vancomycin and Subsequent Risk of Acute Kidney Injury (AKI) among Veterans’ Affairs Patients who have Previously Experienced Vancomycin-associated AKI. Abstract 180. Poster presentation at American Society of Microbiology Microbe Meeting. New Orleans, LA. June 2017. Presenter: Patel. 

Jacqueline Cleary
Davis J, Cleary J, Cardone K.  Assessment of opioid-induced adverse event risk in patients on hemodialysis.  ACCP Virtual Poster Symposium 2017.

Clayton English
Caballero-Manrique E, McMillian WD, English C, Bender SP. “Postoperative Nausea and Vomiting in the Setting of SSRI/SNRI Use.” International Anesthesia Research Society 2017 Annual Meeting and International Science Symposium. Washington, D.C.

English C, Eyler EA, Rabinowitz T. “Psychotropic Medication Adverse Effects Consultation Service.” College of Psychiatric and Neurologic Pharmacists 2017 Annual Convention. Phoenix, AZ.

Jessica Farrell
Farrell JF, Shapiro LS, Miller M. Clinical Pharmacist as Part of the Interprofessional Team Improves Quality of Care in Patients with Rheumatic Disease. Poster Presentation at American College of Rheumatology 2017 Annual Scientific Meeting.  San Diego, CA.  November 5-8, 2017. 

Shapiro LS, Farrell JF, Toledo-Garcia AE, Lukasiewicz R, Magro C, Rosing D, Boehm M, Marmulstein M, Beegle S, Goldin H, Golbus D, Karas M, McCoy H, Merkel PA, Akaya-Smith K.  Systemic Degos Disease: Long Term Survival on Combined Therapy with Eculizumab & Treprostinil.  Poster Presentation at American College of Rheumatology 2017 Annual Scientific Meeting.  San Diego, CA.  November 5-8, 2017.

Gina Garrison
Strang A, Briceland LL, Garrison G, Hamilton RA. Student Reflections on Impact of APPE Learning; School Poster 2017 AACP Annual Meeting, Nashville, TN, July 15, 2017.

Garrison GD. Time Management Strategies for Pharmacist Preceptors. Pharmacy Residency Preceptor Development Continuing Education Program.  St. Peter’s Hospital. Albany, NY (4 small group sessions, ACPE accredited 1 
hour each). June 2017
 
Garrison GD, Seo SW. APhA Pharmacy-based Immunization Delivery National Certificate Program for Pharmacists. Albany College of Pharmacy and Health Sciences. Albany, NY (ACPE accredited 8 hours).

Robert Hamilton
Strang A, Briceland LL, Garrison G, Hamilton RA. Student Reflections on Impact of APPE Learning; School Poster 2017 AACP Annual Meeting, Nashville, TN, July 15, 2017.

Cindy Jablanski
Briceland LL, Strang AF, Jablanski C, Caimano C, Rosa, Kane TS, Brewer JM; Scarpace Peters S. PhIT (Pharmacist-in-Training): An Electronic Portfolio to Document Students’ Personal and Professional Development;  2017 AACP Annual Meeting, Nashville, TN, July 16, 2017.

Michael P. Kane
Stryker MD, Bizier J, Kane MP. Follow-up real-world data in a proprotein convertase subtilisin/kexin type 9 (PCSK9) Inhibitor cohort: Results from a pharmacist-run clinic.  Presented at the 2017 National Lipid Association Scientific Sessions, Philadelphia, PA, May 17, 2017.

Bizier J, Stryker MD, Kane MP. Extended-use proprotein convertase subtilisin/kexin type 9 Inhibitor  (PCSK9i) data in patients with diabetes mellitus: A pharmacist-led initiative. Presented at the 2017 National Lipid Association Scientific Sessions, Philadelphia, PA, May 17, 2017.

Teresa Kane
Briceland LL, Strang AF, Jablanski C, Caimano C, Rosa, Kane TS, Brewer JM; Scarpace Peters S. PhIT (Pharmacist-in-Training): An Electronic Portfolio to Document Students’ Personal and Professional Development;  2017 AACP Annual Meeting, Nashville, TN, July 16, 2017.

Thomas Lodise
Lodise TP, Patel N, Sweeney K, Eckburg PB. Effectiveness and Safety of Intravenous Fosfomycin at Doses of 12-24 g/day in Adult Patients: a Review of the Literature. Abstract 7-087. Poster presentation at the 52st ASHP Midyear Clinical Meeting and Exhibition. Orlando, FL. December 2017. Presenter: Patel.

Patel N, Clark J, Murray J, Bowles J, Lodise TP. Incidence and Predictors of Fluoroquinolone-Associated Adverse Tendon Events among Veterans Affairs Patients with Community Acquired Bacterial Pneumonia. Abstract 66887. Poster presentation at IDWeek 2017TM. San Diego, CA. October 2017. Presenter: Patel.

Patel N, Lo A, Barriere S, Lodise T. Quantitative Evaluation Of Telavancin Exposure-Response Relationships Among Patients In The Assessment Of Telavancin For Treatment Of Hospital-Acquired Pneumonia (ATTAIN) Trials. Late breaker abstract LB2. Poster presentation at American Society of Microbiology Microbe Meeting. New Orleans, LA. June 2017. Presenter: Patel.

J. Nicholas O’Donnell
O’Donnell JN, NJ Rhodes, L Biehle, et al. Mortality Impact of CLSI Carbapenem Breakpoint Changes in Enterobacteriaceae Bloodstream Infections: A Patient-level Analysis of Published Data. Poster Presentation. IDSA ID Week. San Diego, CA. October 2017

O’Donnell JN, MR Bidell, N Patel. Optimal Treatment Of Methicillin-sensitive Staphylococcus Aureus (MSSA) Blood Stream Infections: A Meta-analysis Of Cefazolin Versus Antistaphylococcal Penicillins. Poster Presentation. 2nd annual ASM Microbe. New Orleans, LA. June 2017

O’Donnell JN, CM Miglis, NJ Rhodes, et al. A Randomized Controlled Trial of a Stewardship Intervention (ASI) paired with Matrix Assisted Laser Desorption Ionization Time of Flight (MALDITOF) in Patients with Positive Blood Cultures. Poster Presentation. 2nd annual ASM Microbe. New Orleans, LA. June 2017

O’Donnell JN, CM Miglis, NJ Rhodes, et al. High Dose Intravenous (IV) Vancomycin (VAN) and Expression of Novel Urinary Biomarkers of Acute Kidney Injury (AKI). Poster Presentation. 2nd annual ASM Microbe. New Orleans, LA. June 2017

Sangiovanni RJ, Yager J, Carreno JJ, O’Donnell JN, Lowry C, Carlyn C, Patel N. Retreatment with Vancomycin and Subsequent Risk of Acute Kidney Injury (AKI) among Veterans’ Affairs Patients who have Previously Experienced Vancomycin-associated AKI. Abstract 180. Poster presentation at American Society of Microbiology Microbe Meeting. New Orleans, LA. June 2017. Presenter: Patel. 

Nimish Patel
Najafipour K, Patel N, Cottrell J. Determining the Effect of GLP-1 Agonists on Total Daily Insulin Dose in Veterans Receiving a Basal-Bolus Insulin Regimen. Abstract 1-270. Poster presentation at the 52st ASHP Midyear Clinical Meeting and Exhibition. Orlando, FL. December 2017. Presenter: Najafipour.

Lodise TP, Patel N, Sweeney K, Eckburg PB. Effectiveness and Safety of Intravenous Fosfomycin at Doses of 12-24 g/day in Adult Patients: a Review of the Literature. Abstract 7-087. Poster presentation at the 52st ASHP Midyear Clinical Meeting and Exhibition. Orlando, FL. December 2017. Presenter: Patel.

Patel N, Clark J, Murray J, Bowles J, Lodise TP. Incidence and Predictors of Fluoroquinolone-Associated Adverse Tendon Events among Veterans Affairs Patients with Community Acquired Bacterial Pneumonia. Abstract 66887. Poster presentation at IDWeek 2017TM. San Diego, CA. October 2017. Presenter: Patel.

Britt NS, Patel N, Potter EM, Steed ME. Changing Epidemiology of Carbapenem-Resistant Enterobacteriaceae Bloodstream Infections in United States Veterans Affairs Hospitals, 2004-2014. Abstract 63317. Poster presentation at IDWeek 2017TM. San Diego, CA. October 2017. Presenter: Britt.

Britt NS, Patel N, Potter EM, Steed ME. Polymyxin Monotherapy versus Combination Therapy for the Treatment of Carbapenem-Resistant Enterobacteriaceae Bloodstream Infection: A National Cohort Study. Abstract 63375. Poster presentation at IDWeek 2017TM. San Diego, CA. October 2017. Presenter: Britt.

Britt NS, Steed ME, Potter EM, Patel N. Clinical Outcomes of Methicillin-Resistant Staphylococcus aureus Bacteremia Treated with Ceftaroline Fosamil. Abstract SUN-281. Poster presentation at American Society of Microbiology Microbe Meeting. New Orleans, LA. June 2017. Presenter: Britt.

Patel N, Lo A, Barriere S, Lodise T. Quantitative Evaluation Of Telavancin Exposure-Response Relationships Among Patients In The Assessment Of Telavancin For Treatment Of Hospital-Acquired Pneumonia (ATTAIN) Trials. Late breaker abstract LB2. Poster presentation at American Society of Microbiology Microbe Meeting. New Orleans, LA. June 2017. Presenter: Patel.

Sangiovanni RJ, Yager J, Carreno JJ, O’Donnell JN, Lowry C, Carlyn C, Patel N. Retreatment with Vancomycin and Subsequent Risk of Acute Kidney Injury (AKI) among Veterans’ Affairs Patients who have Previously Experienced Vancomycin-associated AKI. Abstract SAT-180. Poster presentation at American Society of Microbiology Microbe Meeting. New Orleans, LA. June 2017. Presenter: Patel.

O’Donnell JN, MR Bidell, N Patel. Optimal Treatment Of Methicillin-sensitive Staphylococcus Aureus (MSSA) Blood Stream Infections: A Meta-analysis Of Cefazolin Versus Antistaphylococcal Penicillins. Poster Presentation. 2nd annual ASM Microbe. New Orleans, LA. June 2017

Sarah Scarpace Peters
Briceland LL, Strang AF, Jablanski C, Caimano C, Rosa, Kane TS, Brewer JM; Scarpace Peters S. PhIT (Pharmacist-in-Training): An Electronic Portfolio to Document Students’ Personal and Professional Development;  2017 AACP Annual Meeting, Nashville, TN, July 16, 2017.

Sandy Rosa
Rosa S, Briceland LL.  Using APhA Career Pathway Evaluation Program to Aid students in Choosing APPE Rotations and Beyond;  2017 AACP Annual Meeting, Nashville, TN, July 16, 2017.

Briceland LL, Strang AF, Jablanski C, Caimano C, Rosa, Kane TS, Brewer JM; Scarpace Peters S. PhIT (Pharmacist-in-Training): An Electronic Portfolio to Document Students’ Personal and Professional Development;  2017 AACP Annual Meeting, Nashville, TN, July 16, 2017

Joanna Schwartz
Schwartz J. Podium presentation at Northern New England Clinical Oncology Society annual meeting, December 2017, Stowe, VT. Title: Potential herb-chemotherapy or –radiation interactions in patients with cancer: A prospective study of the pharmacist and student pharmacist run herbal assessment service at the University of Vermont Cancer Center.

See-Won Seo 
Garrison GD, Seo SW. APhA Pharmacy-based Immunization Delivery National Certificate Program for Pharmacists. Albany College of Pharmacy and Health Sciences. Albany, NY (ACPE accredited 8 hours).

Cardone KE, Seo S. Delivering Medication Therapy Management in the Community, American Pharmacist’s Association Certificate training program and continuing education for pharmacists. Albany College of Pharmacy and Health Sciences, Albany, NY; October 2017.

Aimee Strang
Briceland LL, Strang AF, Jablanski C, Caimano C, Rosa, Kane TS, Brewer JM; Scarpace Peters S. PhIT (Pharmacist-in-Training): An Electronic Portfolio to Document Students’ Personal and Professional Development;  2017 AACP Annual Meeting, Nashville, TN, July 16, 2017.

Caimano CR, Stack N, Strang AF, Brewer JM. Integration of the Pharmacists' Patient Care Process at Albany College of Pharmacy and Health Sciences. AACP Midyear Meeting, Nashville, TN, July 2017

Strang AF, Briceland LA, Garrison, G, Hamilton RA. Advanced Pharmacy Practice Experience (APPE) Reflections on Learning. AACP Midyear Meeting, Nashville, TN, July 2017

Sidhu MS, Costello K, Strang AF, Brewer JM, Kilby KA, Brodeur M. Inter-Professional Education via Geriatrics Focused 1-Day Program. Association of American Medical Colleges Northeast Group on Educational Affairs (NEGEA) Annual Conference, Rochester, NY, May 2017

Matthew Stryker
Stryker MD, Bizier J, Kane MP. Follow-up real-world data in a proprotein convertase subtilisin/kexin type 9 (PCSK9) Inhibitor cohort: Results from a pharmacist-run clinic.  Presented at the 2017 National Lipid Association Scientific Sessions, Philadelphia, PA, May 17, 2017.

Bizier J, Stryker MD, Kane MP. Extended-use proprotein convertase subtilisin/kexin type 9 Inhibitor  (PCSK9i) data in patients with diabetes mellitus: A pharmacist-led initiative. Presented at the 2017 National Lipid Association Scientific Sessions, Philadelphia, PA, May 17, 2017.

Alexandra Watson
DeRue G, Watson A, Morin C, Guay K, Ribis D. The Impact of Collaborative Pharmacy Care on Medication Adherence. American Managed Care Pharmacy NEXUS Conference. September 2017.

Bidell, M, Watson A. Appropriate use of antibiotics: Upper respiratory infections. Continuing Medical Education. Webinar, Albany, NY. August 2017.

presentations

Laurie Briceland
Briceland LL. Curriculum SIG Affective Domain Presentation. 2017 AACP Annual Meeting, Nashville, TN, July 13, 2017.

Jeffrey Brewer
Caimano C, Lodise NM, Strang AF, Brewer JM.  Integration of the Pharmacists’ Patient Care Process at Albany College of Pharmacy and Health Sciences.  2017 AACP Annual Meeting, Nashville, TN, July16, 2017.

Michael Brodeur
Brodeur MR. Medications and Falls. New York State Council of Health-system Pharmacists Northeast Chapter. September 28, 2017. 

Brodeur MR. Deprescribing. Capital Area Pharmacist Society. September 14, 2017. 

Brodeur MR. Polypharmacy and Falls. Geriatrics Medicine Symposium.  Office of Postgraduate Education. Albany College of Pharmacy and Health Sciences. March 16, 2017.

Kate Cabral
Cabral K, Bidell M. “ Why Complete a Pharmacy Residency & How to Prepare to be a Competitive Candidate.”  ACPHS/NYSCHP Residency Preparation Symposium, ACPHS, Albany, NY. October 2017.

Cabral K, “Expanding Horizons: An Update on Direct Oral Anticoagulant Therapy”
Presented at ‘Barbara DiLascia Women’s & Men’s Health Lecture Series’ ACPE accredited CE conference. Albany College of Pharmacy & Health Sciences, Albany NY. September 2017.

Courtney Caimano
Caimano C, Lodise NM, Strang AF, Brewer JM.  Integration of the Pharmacists’ Patient Care Process at Albany College of Pharmacy and Health Sciences.  2017 AACP Annual Meeting, Nashville, TN, July16, 2017.

Katie Cardone
Cardone KE, Seo S. Delivering Medication Therapy Management in the Community, American Pharmacist’s Association Certificate training program and continuing education for pharmacists. Albany College of Pharmacy and Health Sciences, Albany, NY; October 2017. 

Cardone KE. Peritoneal, Home, and Nocturnal Dialysis: Outpatient dialysis techniques and their impact on drug dosing. Continuing education program for pharmacists. American College of Clinical Pharmacy 2017 Annual Meeting, Phoenix, AZ, October 2017.

Cardone KE. The Present and Future of Diabetes Management for Individuals with CKD: Pharmacokinetics of Diabetes Medication. Continuing education. National Kidney Foundation 2017 Spring Clinical Meeting, Orlando, FL, April 2017. 

Cardone KE. To Dose or Not to Dose?: Medication Safety in CKD. Continuing education. National Kidney Foundation 2017 Spring Clinical Meeting, Orlando, FL, April 2017. 

Cardone KE. Nephrology Review for the Ambulatory Care Pharmacist. Review and recertification course for board certified ambulatory care pharmacists (BCACP). American College of Clinical Pharmacy 2017 Spring Conference, Jacksonville, FL, February 2017.

Cardone KE, Seo S. Delivering Medication Therapy Management in the Community. Certificate training program and continuing education for pharmacists. Albany College of Pharmacy and Health Sciences, Albany, NY; February 2017. 

Joseph Carreno
Carreno JJ. “The Joint Commission’s New Antimicrobial Stewardship Standard: What Every Clinician Needs to Know,” Vermont Society of Health-Systems Pharmacists, Manchester, Vermont (60 minute knowledge based continuing pharmacy education program)

Carreno JJ. “Zika Virus: Update” Albany College of Pharmacy and Health Sciences Infectious Diseases Symposium, Albany, New York (60 minute knowledge based continuing pharmacy education program)

Jacqueline Cleary
Cleary J. PharmasKnowGenetics vs. Pharmacogenetics Unveiled.  PainWeek 2017, Las Vegas, NV September 7, 2017.
 
Cleary J. Interdisciplinary Integration of Next Generation Pharmacists.  PainWeek 2017, Las Vegas, NV September 8, 2017.  
 
Cleary J. Hot Topics for Debate in Pain Management: Risk Mitigation, Multi-modal Analgesia, and Management of Frequent Flyers to the Emergency Room.  Continuing Education Presented at New York State Council of Health-system Pharmacists.  Bolton Landing, New York, April 28, 2017. 

Brian Cowles
Cowles B. invited panel discussion on new faculty development, Pediatric Pharmacy Advocacy Group Annual Meeting, May 2018, Salt Lake City, UT 

Clayton English
English C. Antipsychotics in the Elderly. Invited continuing education presentation at Albany College of Pharmacy and Health Sciences, Colchester, Vermont. March 2017.

English C. Updates in Antipsychotic Pharmacotherapy. Invited presentation to the medical staff of Vermont Psychiatric Care Hospital, Berlin, Vermont. Vermont. April 2017.

English C. Pharmacological Management of Agitation in the context of Schizophrenia & Bipolar Affective Disorder. Invited Grand Rounds presentation to the emergency medicine department staff of University of Vermont Medical Center, Burlington, Vermont. November 2017.

Jessica Farrell
Farrell JF. Clinical Application and FDA Guidance on Interchangeability of Biosimilars:  An Expert Panel Presentation Presented to pharmacists, an ACPE-accredited CE program at the American Society of Health-System Pharmacists (ASHP) 2017 Midyear Clinical Meeting and Exhibition. Orlando, FL. December 5, 2017. 

Farrell JF. Review of Therapeutics for Rheumatology Nurses Presented to rheumatologists and rheumatology health professionals at the American College of Rheumatology 20157 Annual Scientific Meeting.  San Diego, CA.  November 7, 2017.  

Farrell, JF.  Biologics in Autoimmune Disorders: Clinical Considerations for Non-Specialist Pharmacists. Presented to pharmacists, an ACPE-accredited 1.5 hour CE program at the Vermont Pharmacist Association.  Rutland, VT. October 15, 2017.

Farrell JF.  Safety Considerations for the Use of Biologic Therapies in Autoimmune Disorders. Presented to pharmacists, an ACPE-accredited 1 hour CE program at Albany College of Pharmacy and Health Sciences.  May 16, 2017.

Farrell JF.  The Role of a Pharmacist in Rheumatic Diseases. Presented to pharmacists, an ACPE-accredited CE program at the American Pharmacists Association (APhA) 2017 Annual Meeting and Exposition. San Francisco, CA. March 27, 2017. 

Farrell JF.  Treatment Strategies for Osteoarthritis:  Balancing Efficacy and Safety. Presented to pharmacists, an ACPE-accredited 1 hour CE program at Albany College of Pharmacy and Health Sciences.  March 16, 2017.

Andy Flynn
Flynn A.  Continuing Education program for the Capital Area Pharmacists Society: Legislative Issues Affecting Pharmacy in New York State; March 5, 2017

Gina Garrison
Garrison GD, Strang AF.  Use of the Exam Strength and Opportunity Reports to Improve Study Habits. Examsoft Online Learning Series (1 hour national webinar). August 2017.
 
Garrison GD, Strang AF.  Guiding Student Use of Exam Strength and Opportunity Reports to Improve Study Habits. Examsoft National Conference, Denver, CO (1.5 hour live session). June 2017

Darren W. Grabe
Grabe DW. Therapeutic Advances in Hyperkalemia: A Pharmacist’s Guide to Patient Identification and Treatment. North American Center for Continuing Medical Education (NACCME). Pharmacy Learning Network Regional Meeting, Orlando, FL. April 2017

Grabe DW. Therapeutic Advances in Hyperkalemia: A Pharmacist’s Guide to Patient Identification and Treatment. North American Center for Continuing Medical Education (NACCME). Pharmacy Learning Network Regional Meeting, Newark, NJ. May 2017

Grabe DW. Therapeutic Advances in Hyperkalemia: A Pharmacist’s Guide to Patient Identification and Treatment. North American Center for Continuing Medical Education (NACCME). Pharmacy Learning Network Regional Meeting, Washington, DC. September 2017

Grabe DW. Therapeutic Advances in Hyperkalemia: A Pharmacist’s Guide to Patient Identification and Treatment. North American Center for Continuing Medical Education (NACCME). Pharmacy Learning Network Regional Meeting, Boston, MA. October 2017

Elizabeth Higdon
Higdon ERB. Introduction to Pharmacology. Occupational therapy students at University of North Dakota, September 19, 2017.

Michael P. Kane
Kane, MP. Geriatrics Symposium: Osteoporosis Screening, Diagnosis and Treatment in Older Adults. Presented at the Albany College of Pharmacy and Health Sciences, March 16, 2017, Albany, NY. 

Kane, MP. ACCP 2017 Updates In Therapeutics: The Ambulatory Care Pharmacy Preparatory Review Course; Endocrine Disorders.    Presented Endocrine Disorders section of the Ambulatory Care Pharmacy Preparatory Review Course which is offered in    preparation of the pharmacy Specialty Certification Examination for Board Certification in Ambulatory Care. Presented February 17, 2017, Jacksonville, FL.

Nicole Lodise
Caimano C, Lodise NM, Strang AF, Brewer JM.  Integration of the Pharmacists’ Patient Care Process at Albany College of Pharmacy and Health Sciences.  2017 AACP Annual Meeting, Nashville, TN, July16, 2017.

Aimee Strang
Strang AF. An Elective Course to Engage Students in Accreditation. Northeast Association for Institutional Research (NEAIR) Annual Conference. Jersey City, NJ. Nov 2017.

Strang AF. Creating an Assessment Plan to Evaluate Student Professionalism. Northeast Association for Institutional Research (NEAIR) Annual Conference. Jersey City, NJ. Nov 2017.

Strang AF. Using Organigraphs to Improve Your Assessment System. Indiana University Pursue Universary Indianiapolis (IUPUI) Assessment Institute. Indianapolis, IN. Oct 2017. 

Garrison GD, Strang AF.  Use of the Exam Strength and Opportunity Reports to Improve Study Habits. Examsoft Online Learning Series (1 hour national webinar). August 2017.

Garrison GD, Strang AF.  Guiding Student Use of Exam Strength and Opportunity Reports to Improve Study Habits. Examsoft National Conference, Denver, CO (1.5 hour live session). June 2017

Strang AF. How to Create Meaningful Rubrics for Student Assessment. ExamSoft Annual Assessment Conference. Denver, CO. June 2017.

Strang AF. Peer Assessment of Professionalism. ExamSoft Annual Assessment Conference. Denver, CO. June 2017

Strang AF. Using Rubric Scoring Reports to Improve the Assessment Process. ExamSoft Annual Assessment Conference. Denver, CO. June 2017.

Strang AF. Creating an Assessment Plan to Measure Student Outcomes. Capital District Educational Technology Group (CDETG). Empire State College, Saratoga, NY. June 2017.

Strang AF. Creating Meaningful Rubrics for Student Assessment. ExamSoft Webinar, accessible at: https://www.slideshare.net/examsoft/how-to-create-meaningful-rubrics-for-student-assessment . Jan 2017

Caimano C, Lodise NM, Strang AF, Brewer JM.  Integration of the Pharmacists’ Patient Care Process at Albany College of Pharmacy and Health Sciences.  2017 AACP Annual Meeting, Nashville, TN, July16, 2017.

Alexandra Watson
Watson A, Bidell M. Appropriate Use of Antibiotics – Upper Respiratory Infections. Continuing Medical Education Webinar, Enduring Material – 1 AMA PRA Category 1 Credits. CapitalCare Medical Group/Albany Medical College, Albany, NY. August 2017. 

Watson A. Geriatric Pharmacology – High Risk Medications. Continuing Medical Education Webinar, Enduring Material – 1 AMA PRA Category 1 Credits. CapitalCare Medical Group/Albany Medical College, Albany, NY. August 2017. 

Watson A. Updates in Diabetes. Continuing Medical Education Webinar, Enduring Material – 1 AMA PRA Category 1 Credits. CapitalCare Medical Group/Albany Medical College, Albany, NY. August 2017. 

Watson A. CapitalCare Medical Group Diabetes Support Group: Innovations in Diabetes Medications. March 2017. 

Watson A. Update in Diabetes Medications and Their Place in Therapy. ACPE Accredited Continuing Pharmacy Education. New York State Council of Health-system Pharmacists – Northeastern Chapter Meeting, Albany, NY, February 2017. 

Watson A. New Medication Update and Their Place in Therapy. ACPE Accredited Continuing Pharmacy Education. Pharmacists’ Society of the State of New York Mid-Winter Conference, Albany, NY, January 2017.

Yi Zhou
Zhou Y. Management and Treatment of Polycystic Ovary Syndrome. Continuing Education. ACPHS, Albany, NY, September 2017

Grants 

Thomas Lodise
*TITLE: REAL-WORLD EFFECTIVENESS AND SAFETY OF FLUOROQUINOLONES VERSUS OTHER ANTIMICROBIALS AMONG ELDERLY, HOSPITALIZED VETERANS’ AFFAIRS PATIENTS WITH COMMUNITY ACQUIRED BACTERIAL PNEUMONIA
Funding Source: Society of Infectious Diseases Pharmacists 
Amount: $30,000
Performance dates: 10/1/17 – 9/30/18
Role: Principal Investigator
Principal Investigator: Thomas Lodise, Pharm.D., Ph.D. & Nimish Patel, Pharm.D., Ph.D.

*TITLE: IDENTIFICATION OF PATIENTS POPULATIONS WITH ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS AT GREATEST RISK FOR PROLONGED HOSPITAL STAY AND HOSPITAL RE-ADMISSIONS WITH EMPIRIC TREATMENT WITH VANCOMYCIN
Funding Source: Motif, Inc. 
Amount: $34,999
Performance dates: 9/1/17 – 8/31/18
Role: Principal Investigator
Principal Investigator: Thomas Lodise, Pharm.D., Ph.D. & Nimish Patel, Pharm.D., Ph.D.

*TITLE: COMPARATIVE EFFECTIVENESS OF EARLY-TARGETED USE OF FIDAXOMICIN VERSUS ORAL VANCOMYCIN AMONG HOSPITALIZED VETERANS’ AFFAIRS PATIENTS WITH INFECTIONS DUE TO CLOSTRIDIUM DIFFICILE
Funding Source: Merck & Co, Inc. 
Amount: $76,483
Performance dates: 7/1/17 – 12/31/18
Role: Co-Principal Investigator
Principal Investigator: Thomas Lodise, Pharm.D., Ph.D. & Nimish Patel, Pharm.D., Ph.D.

*TITLE: An Open-Label Pharmacokinetic Study of Minocycline for Injection Following a Single Infusion in Critically-Ill Adults (ACUMIN)  
Funding Source: National Institute of Allergy and Infectious Diseases (NIAID)
Funding Mechanism: 1UM1AI104681-01
Amount at ACPHS: $ 102, 851.07
Performance Dates:12/01/15- 11/30/18
Role: co-Investigator
PRINCIPAL INVESTIGATOR: Richard Wunderlink, M. D. 

*TITLE: PK ARLG Steering Committee Chair 
Funding Source: National Institute of Allergy and Infectious Diseases (NIAID)
Funding Mechanism: 1UM1AI104681-01
Amount at ACPHS: $ 62,358
Performance Dates: 12/01/15- 11/30/17
Role: Chair
PRINCIPAL INVESTIGATOR: Vance Fowler, M. D

Nimish Patel
*TITLE: REAL-WORLD EFFECTIVENESS AND SAFETY OF FLUOROQUINOLONES VERSUS OTHER ANTIMICROBIALS AMONG ELDERLY, HOSPITALIZED VETERANS’ AFFAIRS PATIENTS WITH COMMUNITY ACQUIRED BACTERIAL PNEUMONIA
Funding Source: Society of Infectious Diseases Pharmacists 
Amount: $30,000
Performance dates: 10/1/17 – 9/30/18
Role: Principal Investigator
Principal Investigator: Thomas Lodise, Pharm.D., Ph.D. & Nimish Patel, Pharm.D., Ph.D.

*TITLE: IDENTIFICATION OF PATIENTS POPULATIONS WITH ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS AT GREATEST RISK FOR PROLONGED HOSPITAL STAY AND HOSPITAL RE-ADMISSIONS WITH EMPIRIC TREATMENT WITH VANCOMYCIN
Funding Source: Motif, Inc. 
Amount: $34,999
Performance dates: 9/1/17 – 8/31/18
Role: Principal Investigator
Principal Investigator: Thomas Lodise, Pharm.D., Ph.D. & Nimish Patel, Pharm.D., Ph.D.

*TITLE: COMPARATIVE EFFECTIVENESS OF EARLY-TARGETED USE OF FIDAXOMICIN VERSUS ORAL VANCOMYCIN AMONG HOSPITALIZED VETERANS’ AFFAIRS PATIENTS WITH INFECTIONS DUE TO CLOSTRIDIUM DIFFICILE
Funding Source: Merck & Co, Inc. 
Amount: $76,483
Performance dates: 7/1/17 – 12/31/18
Role: Co-Principal Investigator
Principal Investigator: Thomas Lodise, Pharm.D., Ph.D. & Nimish Patel, Pharm.D., Ph.D.

Honors and appointments 

Kelly Bach 
American Society of Health-System Pharmacists: New Practitioners Forum Resident Advancement Advisory Group 2017-2018 
Northeastern New York State Council of Health System Pharmacists: Treasurer 2017-2018
Pharmacists Society of the State of New York: ACPHS House of Delegate Representative June 2017    
AACP Pharmacy College Admission Test (PCAT) Prep Advisory Committee 2017- 2018
AACP Awards Committee for the Lab SIG 2017-2018

Laurie Briceland 
Named to AACP Experiential Education Section Committees: Program Committee for 2017-19

Michael Brodeur 
Elected the AACP Faculty Delegate.
Promoted from Associate to Full Professor

Kate Cabral
Promoted from Assistant to Associate Professor

Courtney Caimano 
Named to AACP Experiential Education Section Committees: Webinar Committee for 2017-19
New York State Council of Health System Pharmacists – President, Northeastern Chapter

Katie Cardone 
Section Advisory group member on Medication Therapy Management in the Community, American Society of Health-System Pharmacy, 2016-2017

Joseph Carreno
New York State Antimicrobial Resistance Task Force

Jessica Farrell
Appointed to the Medical and Scientific Advisory Board for the Scleroderma Foundation as the first non-MD member 

David Kile
Re-elected the member representative in the Government/Education class at Hixny and will again be serving as Treasurer of the Board of Directors of Hixny in 2018.

Nicole Lodise 
Public Health Special Interest Group, Tobacco Control Committee, Chair; American Association of Colleges of Pharmacy (AACP). 

Section of Teachers of Pharmacy Practice Faculty Development Committee, Chair, American Association of Colleges of Pharmacy (AACP).

Women’s Health PRN, Chair-Elect. American College of Clinical Pharmacy (ACCP)

Promoted from Associate to Full Professor

J. Nicholas O’Donnell
10/2017- Present: Faculty for ASHP Infectious Diseases Pharmacy Specialty Review Program.

Joanna Schwartz
Promoted from Assistant to Associate Professor

Kimberly Skylstad
Promoted from Instructor to Assistant Professor

Alexandra Watson
New York State Council of Health System Pharmacists – Secretary, Northeastern Chapter

Awards 

Monique Bidell 
Named 2017 NYS ACCP EDUCATOR/PRECEPTOR of the Year.

Abby Boire
Nominated for 2016-2017 Student Choice Award (Vermont Campus Teacher of the Year).

Jeffrey Brewer
2017 ACPHS SGA Administrator of the Year

Joseph Carreno
2017 Albany College of Pharmacy Preceptor of the Year

Jessica Farrell
Recognition in “The Rheumatologist” for service at The Center for Rheumatology 

Katie Cardone 
Provost Technology Award recipient 2017, ‘Rogue One: Putting PTPM Nephrology Online,’ online course development for PTPM Nephrology at Albany College of Pharmacy and Health Sciences.  

Honored Inducted as a Fellow of the American College of Clinical Pharmacy, American College of Clinical Pharmacy 2017 Annual Meeting, Phoenix, AZ, October 2017. 

Clayton English
University of Vermont Psychiatry Department Award for Excellence in Academic Teaching (June 2017)
ACPHS-Vermont Teacher of the Year (April 2017)
Nominated for 2016-2017 Teacher of the Year.

Jessica Farrell
Recognized in “The Rheumatologist” for service at The Center for Rheumatology.

Darren Grabe 
Awarded the 2017 Provost’s Technology Award.

Elizabeth Higdon
Nominated for 2016-2017 Student Choice Award (Vermont Campus Teacher of the Year).

Judy Nasca
Nominated for 2016-2017 Student Choice Award (Vermont Campus Teacher of the Year).

Joanna Schwartz
Nominated for 2016-2017 Teacher of the Year.

Alexandra Watson
Albany College of Pharmacy New Preceptor of the Year

2016 Scholarly activity report

The activities listed below are by members of the Department of Pharmacy Practice and span the period from January 1, 2016 - December 31, 2016.

publications

Monique Bidell
Bidell MR, McLaughlin M, Faragon J, Morse C, Patel N. Desirable Characteristics of Hepatitis C Treatment Regimens: A Review of What We Have and What We Need. Infectious Diseases and Therapy 2016 Jul 6 (ePub ahead of print).

Lodise TP, Bidell MR, Flanagan SD, Zasowski EJ, Minassian SL, Prokocimer P. Characterization of the haematological profile of 21 days of tedizolid in healthy subjects. Journal of Antimicrobial Chemotherapy 2016 Jun 17 (ePub ahead of print).

Bidell MR, Lodise TP. Fluoroquinolone-Associated Tendinopathy: Does Levofloxacin Pose the Greatest Risk? Pharmacotherapy 2016 May 3 (ePub ahead of print).

Bidell MR, Palchak M, Mohr J, Lodise TP. Fluoroquinolone and Third-Generation Cephalosporin Resistance among Hospitalized Patients with Urinary Tract Infections Due to Escherichia coli: Do Rates Vary by Hospital Characteristics and Geographic Region? Antimicrobial Agents and Chemotherapy 2016 Apr 22;60(5):3170-3.

Katie Cardone
Parker WM, Ferreira K, Vernon L, Cardone KE. The delicate balance of keeping it all together: Using social capital to manage multiple medications for patients on dialysis. Research in Social and Administrative Pharmacy, 2016 Aug 3 (ePub ahead of print).

Davis JM, Wegrzyn N, Cardone KE. Sweetening the deal: Effects of SGLT-2 inhibitors in kidney disease progression. iForumRx, November 2016.

Jo Carreno
Carreno JJ, Kenney RM, Divine G, Vazquez JA, Davis SL. Randomized Controlled Trial to Determine the Efficacy of Early Switch From Vancomycin to Vancomycin Alternatives as a Strategy to Prevent Nephrotoxicity in Patients With Multiple Risk Factors for Adverse Renal Outcomes (STOP-NT). Annals of Pharmacotherapy, 2016 Nov 11.

Carreno JJ, Lomaestro B, Jacobs AM, Meyers RM, Evans A, Montero C. Assessment of Time to Clinical Response in Patients with Sepsis Treated Before and After a Implementation of a Matrix-Assisted Laser Desorption Ionization Time of Flight Based Blood Culture Identification Algorithm. Infection Control & Hospital Epidemiology, 2016 Aug;37(8):916-23. doi: 10.1017/ice.2016.105.

Jacqueline Cleary
Cleary J, Nicewicz K, Fudin J. Life-Saving Naloxone: Review of Currently Approved Products. Practical Pain Management, 2016 September 16(7).

Atkinson TJ, Pratt Cleary J, Fudin J. 10 Pain Medication Myths: Challenges in Selecting the Appropriate Analgesic. Practical Pain Management, 2016 July/August 16(6): 63-70.

Thomas Lodise
Rahbar AJ, Lodise TP, Abraham P, Lockwood A, Pai MP, Patka J, Rabinovich M, Curzio K, Chester K, Williams B, Morse B, Chaar M, Huang V, Salomone J. Pharmacokinetic and Pharmacodynamic Evaluation of Doripenem in Critically Ill Trauma Patients with Sepsis. Surgical Infections (Larchmt), 2016 Dec;17(6):675-682.

Rhodes NJ, Prozialeck WC, Lodise TP, Venkatesan N, O'Donnell JN, Pais G, Cluff C, Lamar PC, Neely MN, Gulati A, Scheetz MH. Evaluation of Vancomycin Exposures Associated with Elevations in Novel Urinary Biomarkers of Acute Kidney Injury in Vancomycin-Treated Rats. Antimicrobial Agents and Chemotherapy, 2016 Sep 23;60(10):5742-51.

Lodise TP, Bidell MR, Flanagan SD, Zasowski EJ, Minassian SL, Prokocimer P. Characterization of the haematological profile of 21 days of tedizolid in healthy subjects. Journal of Antimicrobial Chemotherapy, 2016 Sep;71(9):2553-8.

Jensen IS, Wu E, Fan W, Lodise TP, Nicolau DP, Dufour S, Cyr PL, Sulham KA. Use of Oritavancin in Moderate-to-Severe ABSSSI Patients Requiring IV Antibiotics: A U.S. Payer Budget Impact Analysis. Journal of Managed Care & Specialty Pharmacy, 2016 Jun;22(6):752-64. doi: 10.18553/jmcp.2016.22.6.752.

Bidell MR, Palchak M, Mohr J, Lodise TP. Fluoroquinolone and Third-Generation-Cephalosporin Resistance among Hospitalized Patients with Urinary Tract Infections Due to Escherichia coli: Do Rates Vary by Hospital Characteristics and Geographic Region? Antimicrobial Agents and Chemotherapy, 2016 Apr 22;60(5):3170-3.

Jensen IS, Lodise TP, Fan W, Wu C, Cyr PL, Nicolau DP, DuFour S, Sulham KA. Use of Oritavancin in Acute Bacterial Skin and Skin Structure Infections Patients Receiving Intravenous Antibiotics: A US Hospital Budget Impact Analysis. Clinical Drug Investigation, 2016 Feb;36(2):157-68.

Lodise TP, Fan W, Sulham KA. Economic Impact of Oritavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in the Emergency Department or Observation Setting: Cost Savings Associated with Avoidable Hospitalizations. Clinical Therapeutics, 2016 Jan 1;38(1):136-48.

Moise PA, Culshaw DL, Wong-Beringer A, Bensman J, Lamp KC, Smith WJ, Bauer K, Goff DA, Adamson R, Leuthner K, Virata MD, McKinnell JA, Chaudhry SB, Eskandarian R, Lodise T, Reyes K, Zervos MJ. Comparative Effectiveness of Vancomycin Versus Daptomycin for MRSA Bacteremia With Vancomycin MIC >1 mg/L: A Multicenter Evaluation. Clinical Therapeutics, 2016 Jan 1;38(1):16-30.

Bidell MR, Lodise TP. Fluoroquinolone-Associated Tendinopathy: Does Levofloxacin Pose the Greatest Risk? Pharmacotherapy, 2016 Jun;36(6):679-93.

Martirosov DM, Lodise TP. Emerging trends in epidemiology and management of infections caused by carbapenem-resistant Enterobacteriaceae. Diagnostic Microbiology and Infectious Diseases, 2016 Jun;85(2):266-75.

J. Nicholas O’Donnell
Rhodes NJ, Prozialeck WC, Lodise TP, Venkatesan N, O'Donnell JN, Pais G, Cluff C, Lamar PC, Neely MN, Gulati A, Scheetz MH. Evaluation of vancomycin exposures associated with elevations in novel urinary biomarkers of acute kidney injury in vancomycin-treated rats. Antimicrobial Agents and Chemotherapy 2016; 60: 5742-5751.

Whited L, Grove M, Rose D, Rhodes NJ, Scheetz MH, O'Donnell JN, Neeb J, Thoele K, Jones DR, Lowe C, Moore D, Kiel PJ. Pharmacokinetics of cefepime in patients with cancer and febrile neutropenia in the setting of hematologic malignancies or hematopoietic cell transplantation. Pharmacotherapy 2016; 36: 1003-1010.

O’Donnell JN, O’Donnell EP, Gulati A, Lavhale MS, Kumar EJ, Scheetz MH. Centhaquin citrate pharmacokinetics in a dog model. Journal of Pharmacy and Pharmacology 2016; 68: 803-809.

Scheetz MH, Crew PE, Miglis C, Gilbert EM, Sutton SH, O’Donnell JN, Postelnick M, Zembower T, Rhodes NJ. Investigating the extremes of antibiotic use with an epidemiologic framework. Antimicrobial Agents and Chemotherapy 2016; 60: 3265-3269.

O’Donnell JN, Miglis CM, Lee JY, Tuvell M, Lertharakul T, Scheetz MH. Carbapenem susceptibility breakpoints, clinical implications with the moving target. Expert Review of Anti-infective Therapy; 14: 389-401.

O’Donnell JN, Venkatesan N, Manek M, Rhodes NJ, Scheetz MH. Visual and absorbance analyses of vancomycin and piperacillin-tazobactam incompatibilities at a range of commonly utilized doses. American Journal of Health-System Pharmacy 2016; 73: 241-246.

Rhodes NJ, O’Donnell JN, Lizza BD, Mclaughlin MM, Esterly JS, Scheetz MH. Tree based models for the prediction of mortality in Gram negative bacteremia: avoid putting the CART before the horse. Antimicrobial Agents and Chemotherapy 2016; 60: 838-844.

O’Donnell JN, Gulati A, Lavhale MS, Sharma SS, Patel AJ, Rhodes NJ, Scheetz MH. Pharmacokinetics of centhaquin citrate in a rat model. Journal of Pharmacy and Pharmacology 2016; 68: 56-62.

Nimish Patel
Bidell MR, McLaughlin M, Faragon J, Morse C, Patel N. Desirable Characteristics of Hepatitis C Treatment Regimens: A Review of What We Have and What We Need. Infectious Diseases and Therapy, 2016 Sep;5(3):299-312. doi: 10.1007/s40121-016-0118-x. Epub 2016 Jul 6. Review.

Britt NS, Potter EM, Patel N, Steed ME. Comparative Effectiveness and Safety of Standard-, Medium-, and High-Dose Daptomycin Strategies for the Treatment of Vancomycin-Resistant Enterococcal Bacteremia Among Veterans Affairs Patients. Clinical Infectious Diseases 2016 Dec 22. pii: ciw815. doi: 10.1093/cid/ciw815 (ePub ahead of print).

Britt NS, Patel N, Shireman TI, El Atrouni WI, Horvat RT, Steed ME. Relationship between vancomycin tolerance and clinical outcomes in Staphylococcus aureus bacteraemia. Journal of Antimicrobial Chemotherapy 2016 Dec 20. pii: dkw453. doi: 10.1093/jac/dkw453 (ePub ahead of print).

Britt NS, Patel N, Horvat RT, Steed ME. Vancomycin 24-Hour Area under the Curve/Minimum Bactericidal Concentration Ratio as a Novel Predictor of Mortality in Methicillin-Resistant Staphylococcus aureus Bacteremia. Antimicrobial Agents and Chemotherapy 2016 Apr 22;60(5):3070-5. doi: 10.1128/AAC.02714-15, May 2016.

Joanna Schwartz
Moukharskaya J, Abrams DM, Khan FB, Schwartz J, Ades S, Ashikaga T. Randomized Phase 2 Study of Loratadine for the prevention of bone pain cause by pegfilgrastim. Supportive Care Cancer, July 2016; 24(7): 3085-3093.

Kimberly Skylstad
Garren T, Skylstad KA. Scaffolded Online Learning Modules for Milliequivalency and Milliosmolarity. Currents in Pharmacy Teaching and Learning 2016;8:316-322.

Aimee Strang
Baia P, Strang AF. Pharmacy Educator Motives to Pursue Pedagogical Knowledge. American Journal of Pharmaceutical Education, 2016; 80(8): 132.

Strang AF, Baia P. An Investigation of Teaching and Learning Programs in Pharmacy Education. American Journal of Pharmaceutical Education, 2016; 80(4):59.

Lamba S, Strang A, Edelman D, Navedo D, Soto-Greene ML, Guarino AJ. Promoting interprofessionalism: initial evaluation of a master of science in health professions education degree program. Advances in Medical Education and Practice, 2016; 7: 51–5.

Matthew Stryker
Stryker M, Kane M, Busch R. Lack of Cross-Reactivity Following a Switch from Alirocumab to Evolocumab. Excerpts in Pharmacy Research Journal 2016;2:1-2.

Stryker M, Kane M, Busch R. A Pharmacist-Run Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor Clinic: Short-Tem Results and Practical Strategies. Pharmacotherapy 2016;36(7)e83-e138.

Stryker M, Kane M, Busch R. An Evaluation of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors in Patients with Diabetes Mellitus. Journal of Clinical Lipidology, 10(3):720, May 2016.

Michael Kane
Stryker MD, Kane MP, Busch RS. Lack of Cross-Reactivity Allergy Following a Switch from Alirocumab to Evolocumab. Excerpts in Pharmacy Research Journal, 2016;2:1-3.

Stryker MD, Kane MP, Busch RS. An Evaluation Of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors In Patients With Diabetes Mellitus. Journal of Clinical Lipidology, 10(3):720, May 2016.

Saroka RM, Kane MP, Robinson L, Busch RS. No postoperative adrenal insufficiency in a patient with unilateral cortisol-secreting adenomas treated with mifepristone before surgery. Clinical Med Insights: Endocrinology and Diabetes, 2016;9:31-6.

Kane MP, Hamilton RA. Determination of the glycemic index of a diabetes truffle. Journal of Global Diabetes and Clinical Metabolism, 2016;1:22-4.

Brady SM, Kane MP, Busch RS. GLP-1 Agonist Use in a Patient with an Explainable Cause of Pancreatitis. AACE Clinical Case Reports, Spring, 2016. DOI 10.4158/EP15658.CR.

Jacqueline Cleary
Fudin J, Pratt Cleary J, Sparkes S. “Opioid Analgesics” in Pain Management Secrets, Fourth ED. Dubin, Andrew, et al, Elsevier Health Sciences, 2016 (publication pending).

Jessica Farrell
Farrell JF, Kennedy AG. “Psoriatic Arthritis” in Ambulatory Care Self-Assessment Program (ACSAP), 2016 Book 1, Endocrinologic/Rheumatologic Care. Dong BJ, Elliott DP, eds. Lenexa, KS: American College of Clinical Pharmacy, 2016.

Michael Kane
Jonklaas J, Kane MP. “Thyroid disorders” in Pharmacotherapy: A Pathophysiologic Approach, 10th edition. DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, eds. New York, NY: McGraw-Hill Education, 2016.

Kane MP. “Endocrine Disorders” in Updates in Therapeutics: Ambulatory Care Pharmacy Preparatory Review and Recertification Course, 2016 ed. Bainbridge JL, Cardone K, Cross LB, et al. Lenexa, KS: American College of Clinical Pharmacy, 2016:1-679 - 1-740.

Katie Cardone
Wegrzyn NM, Cardone KE. “Are intravenous iron sucrose products interchangeable? Efficacy and safety of original and generic formulations in hemodialysis patients.” Textbook Update, AccessPharmacy Web site, New York: McGraw-Hill, September 2016.

Cardone KE. “End-Stage Kidney Disease” in Pharmacotherapy Casebook: A Patient-Focused Approach, 10th ed. Schwinghammer TL, Koehler JM, eds., McGraw-Hill, 2016.

Cardone KE. “Nephrology” in Review and Recertification Book for Board Certification in Ambulatory Care Pharmacy. American College of Clinical Pharmacy, 2016.

Presentations

POSTER/PLATFORM PRESENTATIONS

Monique Bidell
Fimansyah A, Nguyen H, Bidell M, Han Z, Pettit NN. Outcomes associated with time-to-antibiotic administration among patients with febrile neutropenia in the emergency department. ASHP Midyear Exhibition, Las Vegas, NV, December 2016.

Brown SJ, Lane SM, Bidell MR. Assessment of institutional fluoroquinolone use for uncomplicated infections. ASHP Midyear Exhibition, Las Vegas, NV, December 2016.

Falli E, Poucher A, Lombardi CL, Ferri D, Bidell MR. Evaluation of an adjusted body weight-based vancomycin dosing guideline. ASHP Midyear Exhibition, Las Vegas, NV, December 2016.

Bidell MR, Lodise TP. Levofloxacin-associated tendinopathy: What is the risk? ACPHS Research Forum, Albany, NY, January 2016; Making A Difference in Infectious Diseases (MAD-ID), Orlando, FL, May 2016.

Laurie Briceland
Rosa S, Briceland L. Introducing students to Pharmacy Ownership through the development of an Entrepreneurial APPE Rotation. 2016 AACP Annual Meeting (abstract).

Briceland L, Rosa S, Lubowski T, Jablanski C. Creation of Experiential Education Honors Policies to Recognize Exemplary IPPE and APPE Performance. AACP Annual Meeting, Anaheim, CA, July 25, 2016 (abstract).

Katie Cardone
Cardone KE, Daoui S, Daoui R, Donato KM, Parker WM. Factors Affecting Medication Management among Patients with Chronic Kidney Disease (abstract SA-PO924). American Society of Nephrology 2016 Kidney Week, Chicago, IL, November 2016. Journal of the American Society of Nephrology 27:2016.

Cardone KE, Zheng H, Balk N, Rivenburg K, DiCenzo R. Promoting Pharmacy through Recruitment for Two Campuses in Two States. American Association of Colleges of Pharmacy Annual Meeting, Anaheim, CA, July 23-27, 2016.  

Parker WM, Wegrzyn NM, Pai AB, Daoui R, Daoui S, Cardone KE. Health Literacy and Self-Management of Medications among Patients at an Outpatient Nephrology Office. AcademyHealth Annual Research Meeting, Boston, MA, June 27, 2016.

Wegrzyn NM, Parker WM, Pai AB, Daoui R, Daoui S, Cardone KE. Assessing health literacy in outpatient nephrology patients. National Kidney Foundation Spring Clinical Meeting, Boston, MA, April 2016.

Brian Cowles
Lipinksi H, Cowles B, Young L. Dobutamine-induced rash in a critically ill full-term neonate: A case report. ASHP Midyear Clinical Meeting, Las Vegas, NV, December 6, 2016.

Jessica Farrell
Farrell JF. Pharmacist-Developed Letters Used to Obtained Inclusion of Off-Label Indications of Rheumatic Drugs within National Compendia. Scleroderma Foundation National Patient Education Conference, New Orleans, LA, July 2016.

Loy T, Farrell JF, Bruce SP. Pharmacist- and student-developed letters to national compendia to acquire off-label status. ASHP Midyear Clinical Meeting & Exhibition, Las Vegas, NV, December 2016.

Gina Garrison
Quidort A, Wales D, Garrison GD, Lindstrom J, Verrico I. Improving Immunization Rates of Children Age 19 to 35 months: An Interprofessional Approach at a Multidisciplinary Training Site. American Academy of Pediatrics (AAP) National Conference & Exhibition, San Francisco, CA, October 22-25, 2016.

Michael Kane
Stryker M, Kane M, Busch R, Hamilton R. An Evaluation of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors in Patients with Diabetes Mellitus (abstract 187). National Lipid Association’s Scientific Sessions, New Orleans, LA, May 18, 2016.

Stryker M, Kane M, Busch R, Hamilton R. A Pharmacist-Run Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor Clinic: Short-Term Results and Practical Strategies (poster 97). American College of Clinical Pharmacy’s Virtual Poster Symposium, May 18, 2016.

Bizier J, Kane MP, Busch RS, Bakst G, ElDeiry SE, Hamilton RA. Efficacy and Safety of Switching Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitor Therapy in Type 2 Diabetes Mellitus. ASHP Midyear Clinical Meeting, Las Vegas, NV, December 7, 2016.

Nicole Lodise
Bartelme KM, Lodise NM, Rafie S, Shealy K, Stone R, Vernon V. The Women’s Health PRN Members and Accomplishments. American College of Clinical Pharmacy (ACCP) Annual Meeting, Hollywood, FL, October 2016.

Thomas Lodise
Lodise TP, Ye M, Keyloun KR, Zhao Q, Gillard P. Identification of Patients at Greatest Risk for Carbapenem Resistance in Patients With Serious Hospital-Onset Infections Due to Enterobacteriaceae Species (abstract 1794). Oral Presentation at IDWeek2016, New Orleans, LA, October 26-30, 2016. Presenter: Lodise.

Berger A, Bhagnani T, Wang R, Zhao Q, Ye M, Lodise TP. Does Timing of Receipt of Appropriate Antimicrobial Therapy Make a Difference Among Patients with Serious Infections due to Resistant Gram-negative Pathogens? (abstract 1796). Oral Presentation at IDWeek2016, New Orleans, LA, October 26-30, 2016. Presenter: Lodise.

Luther M, Caffrey A, Dosa D, Lodise TP, LaPlante K. Vancomycin plus Piperacillin/Tazobactam and Acute Kidney Injury in Adults: A Systematic Review and Meta-analysis (abstract 1805). Poster Presentation at IDWeek2016, New Orleans, LA, October 26-30, 2016. Presenter: Luther.

Lodise TP. Wang R, Bhagnani T, Zhao Q, Ye M, Berger A. Clinical and Economic Burden of Multi-drug Resistant Pseudomonas sp. (MDRP) Among Patients with Serious Infections in US Hospitals (abstract 2045). Poster Presentation at IDWeek2016, New Orleans, LA, October 26-30, 2016. Presenter: Lodise.

Mckinnell JA, Corman S, Patel D, Lodise TP. Telavancin vs. Vancomycin in the Treatment of Hospital-Acquired Pneumonia Caused by S. Aureus: Decision Analytic Model (abstract 1250). Poster Presentation at IDWeek2016, New Orleans, LA, October 26-30, 2016. Presenter: Mckinnell JA.

Martin A, Fahrbach K, Zhao Q, Lodise T. Association between Carbapenem Resistance and Mortality among Adults Hospitalized with Serious Infections due to an Enterobacteriaceae spp: Results of a Systematic Literature Review and Meta-Analysis (abstract 355). Poster Presentation at IDWeek2016, New Orleans, LA, October 26-30, 2016. Presenter: Martin.

Natesan S, Pai MP, Lodise TP. Determination of Alternative Ceftolozane/Tazobactam (C/T) Dosing Regimens for Patients with Infections Due to Pseudomonas aeruginosa with high (C/T) MIC values (abstract 1959). Poster Presentation at IDWeek2016, New Orleans, LA, October 26-30, 2016. Presenter: Natesan.

Huang D, Lodise T. Use of PK/PD Systems Analyses to Determine the Optimal Fixed Dosing Regimen of Iclaprim (ICL) for Phase III ABSSSI Clinical Trial. Abstract 1971. Poster Presentation at IDWeek2016™: A Joint Meeting of IDSA, SHEA, HIVMA, and PIDS. New Orleans, LA, October 26-30, 2016. Presenter: Huang.

Carreno JJ, Lomaestro BM, Tietjan J, Lodise T. Validation Of A Bayesian Approach To Estimate Vancomycin Exposure In Obese Patients With Limited PK Sampling (abstract 496). Poster Presentation at ASM Microbe 2016, Boston, MA, June 16-20, 2016. Presenter: Carreno.

O'Donnell J, Rhodes NJ, Lodise T, Prozialeck W, Miglis CH, Natarajan V, Joshi M, Pais G, Lamar P, Cluff C, Gulati A, Scheetz MH. 24-Hour Pharmacokinetic Relationships for Vancomycin (Van) and Novel Urinary Biomarkers of Acute Kidney Injury (abstract 517). Poster Presentation at ASM Microbe 2016, Boston, MA, June 16-20, 2016. Presenter: O'Donnell.

Schriever C, Ahmed A, Delehanty KR, Yager J, Farrow G, Kashtan R, Lodise T, Patel N. Comparison of frequencies of drug-drug interactions between sofosbuvir/ledipasvir and ombitasvir/dasabuvir/paritaprevir/ritonavir +/- ribavirin among HIV/HCV coinfected patients (abstract SAT-223). Poster presentation at the European Association for the Study of the Liver – International Liver Congress, Barcelona, ES, April 2016. Presenter: Patel.

Yager J, Lodise T, Patel N. Minimum adherence threshold necessary to achieve virologic suppression (abstract 1995). Poster presentation at the 26th European Congress on Clinical Microbiology and Infectious Diseases, Amsterdam, NL, April 2016. Presenter: Patel.

Patel N, Yager J, McGuey L, Hoye-Simek A, Lodise T. Relationship between single-tablet regimen and adherence to HIV and non-HIV medications (abstract 1998). Poster presentation at the 26th European Congress on Clinical Microbiology and Infectious Diseases, Amsterdam, NL, April 2016. Presenter: Patel.

Patel N, Hecox Z, Morse C, Sullivan S, Hoye-Simek A, Yager J, Lodise T. Maintenance of non-HIV cardiometabolic comorbidity control among HIV-infected veterans’ affairs patients: a comparison between single tablet and multiple tablet antiretroviral regimens (abstract 1991). Poster presentation at the 26th European Congress on Clinical Microbiology and Infectious Diseases, Amsterdam, NL, April 2016. Presenter: Patel.

Yager J, Lodise T, Patel N. Minimum adherence threshold needed for maintenance of virologic suppression (abstract 1993). Platform presentation at the 26th European Congress on Clinical Microbiology and Infectious Diseases, Amsterdam, NL, April 2016. Presenter: Yager.

J. Nicholas O’Donnell
O’Donnell JN, Rhodes NJ, Lodise TP, Prozialeck WC, Miglis CM, Venkatesan N, Joshi M, Pais G, Lamar PC, Cluff C, Gulati A, Scheetz MH. 24-hour pharmacokinetic relationships for vancomycin and novel urinary biomarkers of AKI. 1st American Society of Microbiology Microbe, Boston, MA, June 2016.

Nimish Patel
Yager J, Lodise T, Patel N. Minimum adherence threshold needed for maintenance of virologic suppression (abstract 1993). Platform presentation at the 26th European Congress on Clinical Microbiology and Infectious Diseases, Amsterdam, NL, April 2016. Presenter: Yager.

Patel N, Hecox Z, Morse C, Sullivan S, Hoye-Simek A, Yager J, Lodise T. Maintenance of non-HIV cardiometabolic comorbidity control among HIV-infected veterans’ affairs patients: a comparison between single tablet and multiple tablet antiretroviral regimens (abstract 1991). Poster presentation at the 26th European Congress on Clinical Microbiology and Infectious Diseases, Amsterdam, NL, April 2016. Presenter: Patel.

Patel N, Yager J, McGuey L, Hoye-Simek A, Lodise T. Relationship between single-tablet regimen and adherence to HIV and non-HIV medications (abstract 1998). Poster presentation at the 26th European Congress on Clinical Microbiology and Infectious Diseases, Amsterdam, NL, April 2016. Presenter: Patel.

Yager J, Lodise T, Patel N. Minimum adherence threshold necessary to achieve virologic suppression (abstract 1995). Poster presentation at the 26th European Congress on Clinical Microbiology and Infectious Diseases, Amsterdam, NL, April 2016. Presenter: Patel.

Schriever C, Ahmed A, Delehanty KR, Yager J, Farrow G, Kashtan R, Lodise T, Patel N. Comparison of frequencies of drug-drug interactions between sofosbuvir/ledipasvir and ombitasvir/dasabuvir/paritaprevir/ritonavir +/- ribavirin among HIV/HCV coinfected patients (abstract SAT-223). Poster presentation at the European Association for the Study of the Liver – International Liver Congress, Barcelona, ES, April 2016. Presenter: Patel.

Britt NS, Potter EM, Patel N, Steed ME. Derivation And Validation Of A Mortality Risk Assessment Model For Vancomycin-Resistant Enterococcal (Vre) Bacteremia Based On Source Of Infection (session 333). Platform presentation at American Society for Microbiology Microbe Meeting, Boston, MA, June 2016. Presenter: Britt.

Britt NS, Potter EM, Patel N, Steed ME. Clinical Outcomes In Vancomycin-Resistant Enterococcus (VRE)/Methicillin-Resistant Staphylococcus aureus (MRSA) Bloodstream Coinfection Treated With Daptomycin Or Linezolid (abstract 396). Poster presentation at American Society for Microbiology Microbe Meeting, Boston, MA, June 2016. Presenter: Britt.

Ahmed AA, Schriever C, Amin R, Delehanty KR, Yager J, Patel N. Comparing the Population-Based Frequency of Contraindicated Drug-Drug Interactions between Daclatasvir/Sofosbuvir (DAC/SOF), Grazoprevir/Elbasvir (GZR/EBV), Ledipasvir/Sofosbuvir (LDV/SOF), Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir ± Ribavirin (OMB/PTV/RTV + DSV ± RBV) and Simeprevir/Sofosbuvir (SIM/SOF) for Treatment of Hepatitis C Monoinfection (abstract 60260). Poster presentation at IDWeek 2016. New Orleans, LA, October 2016. Presenter: Patel.

Yager J, Faragon J, Patel N. Quantifying the minimum adherence threshold associated with the development of reverse transcriptase mutations among HIV-infected Veterans’ Affairs patients receiving antiretroviral therapy (abstract 225954). Poster Presentation at the 2016 ASHP Midyear Clinical Meeting, Las Vegas, NV, December 2016. Presenter: Yager.

Sangiovanni RJ, Yager J, Donadio A, Farrow G, Patel N. Use of vancomycin in VISN-2 patients who have previously experienced vancomycin-associated acute kidney injury (AKI): Predictors and outcomes of secondary vancomycin-associated AKI (abstract 225960). Poster presentation at the 51st ASHP Midyear Clinical Meeting and Exhibition, Las Vegas, NV, December 2016. Presenter: Sangiovanni.

Lee Anna Obos
Obos L. Two Phase Pharmacy Skills Laboratory Video Project: Student Reactions and Effect on Lab Performance, AACP Annual Meeting, Anaheim, CA, July 2016.  

Sandra Rosa
Rosa S, Briceland L. Introducing students to Pharmacy Ownership through the development of an Entrepreneurial APPE Rotation. 2016 AACP Annual Meeting (abstract).

Briceland L, Rosa S, Lubowski T, Jablanski C. Creation of Experiential Education Honors Policies to Recognize Exemplary IPPE and APPE Performance. AACP Annual Meeting, Anaheim, CA, July 25, 2016 (abstract).

Matthew Stryker
Stryker M, Kane M, Busch R, Hamilton R. An Evaluation of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors in Patients with Diabetes Mellitus. 2016 National Lipid Association’s Scientific Sessions, Abstract Identification: 187.

Stryker M, Kane M, Busch R, Hamilton R. A Pharmacist-Run Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor Clinic: Short-Term Results and Practical Strategies. American College of Clinical Pharmacy’s 2016 Virtual Poster Symposium, Poster Number: 97.

INVITED PRESENTATIONS

Kelly Bach
Bach K. Delivering a powerful residency interview presentation. ACPHS/NYSCHP Residency Preparation Symposium, ACPHS, Albany, NY, October 2016.

Monique Bidell
Bidell M. A case of vomiting, malaise and acute injury (co-presented with Yolana Fuks and David Colman). Medical Grand Rounds, St. Peter’s Hospital, Albany, NY, December 2016.

Bidell M. Fluoroquinolone safety: Tipping the risk-benefit scale. PharmaMed 2016, Dubai, United Arab Emirates, December 2016.

Bidell M. Why complete a pharmacy residency and how to prepare to be a competitive candidate (co-presented with Kate Cabral). ACPHS/NYSCHP Residency Preparation Symposium, ACPHS, Albany, NY, October 2016.

Bidell M. Updates in antimicrobial safety: Focus on fluoroquinolones. Continuing Education. Infectious Diseases Symposium, ACPHS, Albany, NY, February 2016.

Abby Boire
Boire A. Updates in Heart Failure Therapy: What the Pharmacist Needs to Know. April 2016.

Jeffrey Brewer
Brewer JM. Professional Organizations Council: AACP Interim Meeting Report, Effective Leadership, Spring 2016.

Laurie Briceland
Briceland L. Overview of Antimicrobial Therapy. Sage College Nurse Practitioner Program, February 2016.

Michael Brodeur
Brodeur MR. FOAM – Free Open Access Medical education – Medical education for anyone, anywhere, anytime. American Society of Consultant Pharmacist Annual Meeting, Dallas, TX, November 4, 2016.

Brodeur MR. Colonie Emergency Medical Services. Continuing Education. November 2016.

Brodeur MR. Falls and Their Prevention: A Geriatrics and Pharmacological Imperative Fall Risk Identification and Intervention for the Community-Dwelling Older Adult. Public Health Live,
SUNY School of Public Health, October 20, 2016.

Brodeur MR. Pill Pruning - The Art and Science of Deprescribing. Office of Postgraduate Education, ACPHS, June 8, 2016.

Brodeur MR. Pain Management in an Era of Uncertainty. Pharmacist Society of
the State of New York (PSSNY), Mid-Winter Meeting, Saratoga, NY, January 30, 2016.

Katherine Cabral
Why Complete a Pharmacy Residency? NYSCHP/ACPHS Residency Prep Symposium, Albany College of Pharmacy and Health Sciences, Albany NY, October 2016.

Through Thick & Thin: An Update on Anticoagulants. Continuing Education. ACPHS Cardiovascular Symposium, Albany College of Pharmacy and Health Sciences, Albany, NY, April 2016.

Katie Cardone
Cardone K. Updates In Type 2 Diabetes Management: Guideline Updates. Continuing Education (co-presented with See-Won Seo). Mohawk Valley Pharmacists Association, Utica, NY, December 2016.

Cardone K. Use of SGLT2 Inhibitors in Treating T2D. Continuing Education. Mohawk Valley Pharmacists Association, Utica, NY, December 2016.

Cardone K. Updates In Type 2 Diabetes Management: Case-Based Discussion Of Diabetes Management. Continuing Education (co-presented with See-Won Seo). Mohawk Valley Pharmacists Association, Utica, NY, December 2016.

Cardone K. Pharmacology, Pharmacokinetics and Pharmacodynamics in Diabetic Kidney Disease: Give It Your Best Shot: Newer Diabetes Agents in CKD. Continuing Education. American Society of Nephrology Kidney Week, Chicago, IL, November 2016.

Cardone K. Newer Agents and Their Implications for Patients with Chronic Kidney Disease: The Current and Potential Role of SGLT-2 Inhibitors in Patients with Chronic Kidney Disease. Continuing Education. Annual Meeting of the American College of Clinical Pharmacy, Hollywood, FL, October 25, 2016.

Cardone K. Delivering Medication Therapy Management in the Community. Continuing Education and Certificate Training Program. Mohawk Valley Pharmacists Association, Utica, NY, Spring 2016.

Cardone K. Update on Diabetic Kidney Disease (DKD) Management: SGLT-2 inhibitors. Continuing Education. National Kidney Foundation Spring Clinical Meeting, Boston MA, May 2016.

Cardone K. Anemia Workshop: Management of ESA Hyporesponse: A Fine Balance. Continuing Education. National Kidney Foundation Spring Clinical Meeting, Boston, MA, May 2016.

Cardone K. Pragmatic Drug Dosing across the Continuum in Kidney Disease: Drug Dosing In Hemodialysis – Time Over Matter? Continuing Education and Active Learning Case Session. National Kidney Foundation Spring Clinical Meeting, Boston, MA, May 2016 (session chair/moderator).

Cardone K. Pragmatic Drug Dosing across the Continuum In Kidney Disease: Drug Dosing In Peritoneal Dialysis. Continuing Education and Active Learning Case Session. National Kidney Foundation Spring Clinical Meeting, Boston, MA, May 2016 (session chair/moderator).

Cardone K. Nephrology Review for the Ambulatory Care Pharmacist Review and recertification course for board certified ambulatory care pharmacists (BCACP). American College of Clinical Pharmacy Spring Conference, Phoenix, AZ, April 2016.

Jo Carreno
Carreno J. Zika Virus: Beyond the Hype. Continuing Education. Capital Area Pharmacists Society, Albany, NY.

Carreno J. The Use of Rapid Diagnostics within Antimicrobial Stewardship Programs. Continuing Education. ACPHS, Albany, NY.

Jacqueline Cleary
Cleary J. Opioid Induced Respiratory Depression and In-Home Naloxone Use: Application of the Risk Index for Overdose or Serious Opioid Induced Respiratory Depression (RIOSORD) Tool. Continuing Education. Alden March Bioethics Institute Clinical Ethics Conference, ACPHS, Albany, NY, November 19, 2016.

Cleary J. Pharmacist’s Role in Naloxone Education and Distribution. Rho Chi and PLS joint meeting, ACPHS, Albany, NY, November 2016.

Cleary J. Opioid Induced Respiratory Depression and Naloxone Distribution: Application of the RIOSORD Tool. Continuing Education. Annual Preceptor Training Day, ACPHS, Albany, NY, August 2016.

Giselle D’Epiro
D’Epiro G. Vitamin Supplementation in Women. University of Vermont Women’s Health Conference, 2016.

D’Epiro G. The New Anticoagulants. UVM Family Medicine Review Course, 2016.

Jessica Farrell
Farrell JF. Proton Pump Inhibitors (PPI): How to Digest the News? Scleroderma Foundation National Patient Education Conference, New Orleans, LA, July 29, 2016.

Farrell JF. The Role of Biologics in Psoriatic Arthritis. Continuing Education. ACPHS, Albany, NY, September 2016.

Gina Garrison
Garrison G. 2016 Annual CDC Immunization Updates for Adult and Infants / Children / Adolescents. AMC Internal Medicine and Pediatrics Group, Latham, NY.

Garrison G. 2016 Updates in Pharmacotherapy for Adult Dyslipidemia. Continuing Education. Albany Medical College – Internal Medicine and Pediatric Update, Saratoga, NY.

Garrison G. 2016 Updates in Pharmacotherapy for Adult Dyslipidemia. Continuing Education. ACPHS Cardiovascular Update, Albany, NY.

Garrison G. Dyslipidemia: Would every woman should know. Capital Region Women’s Business Council, Albany, NY.

Elizabeth Higdon
Higdon E. Calamine Compounding Workshop. Presented to high school students at TRIO event, Colchester, VT, February 2016.

Michael Kane
Kane M. Diabetes Update. American Society of Consulting Pharmacists Mid-State New York Chapter Meeting and Education Day, Syracuse, NY, June 16, 2016.

Kane M. Keynote Address. The Capital District Residency & Fellowship Graduation Luncheon, Albany, NY, June 8, 2016.

Kane M. Strategies for Diabetes Prevention. Mid-Hudson Regional Hospital Pre-diabetes Epidemic Conference: Public Health Impact & Prevention of Type 2 Diabetes, Poughkeepsie, NY, May 14, 2016.

Kane M. Endocrine Disorders. For Ambulatory Care Pharmacy Preparatory Review Course, ACCP 2016 Updates In Therapeutics, Phoenix, AZ, April 9, 2016.

Kane M. The New Classes of Diabetes Medications: A Synopsis. Grand Rounds at the Baystate Medical Center, Springfield, MA, March 22, 2016.

Kane M. Obesity Is a Chronic Disease: Let’s Treat it That Way. APhA Annual Meeting, Baltimore, MD, March 7, 2016.

Teresa Kane
Kane T. Aseptic Technique Training Videos. ACPHS Instructional Design Symposium, Spring 2016.

David Kile
Kile D. Profiles in Leadership Hollywood Version Instructional Design Symposium. ACPHS, March 23, 2016.

Kile D. Medication Adherence: America’s Other Drug Problem. ACPHS Pharmacy Practice Update, June 8, 2016.

Nicole Lodise
Lodise NM. JCPP Pharmacist’s Patient Care Process: Standardizing the Approach to Patient Care. Continuing Education. Albany College of Pharmacy and Health Sciences Barbara M. DiLascia Women's and Men's Health Symposium, Albany, NY, September 2016.

Lodise NM. Curricular Adoption and Integration of the Pharmacists’ Patient Care Process. American Association of Colleges of Pharmacy (AACP) Teachers’ Seminar, Anaheim, CA, July 2016.

Thomas Lodise
Vancomycin PK/PD Efficacy (symposium). “Contemporary Considerations: Cutting Edge Advances in Vancomycin Therapy.” 2016 ASHP Midyear Clinical Meeting Las Vegas, NV, December 7, 2016.

Exposure-Centric vs. Dose-Centric Drug Development Approach (workshop). “Opportunities and challenges in development of new antibacterial therapeutics.” Superbugs & Superdrugs USA 2016, Iselin, NJ, November 16, 2016.

The Drug: Update on Treatment Options (satellite symposium). “The Bug-Drug-Host Triad in the Era of Antibiotic Resistance: Focus on the Spectrum of ABSSSI.” IDWeek2016, New Orleans, LA, October 28, 2016.

Economics of Treating ABSSSI in Different Settings of Care (satellite symposium). IDWeek2016, New Orleans, LA, October 27, 2016.  

PK/PD versus frequentist approaches for drug development – Pro (debate). ESCMID/ASM Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance. Vienna, Austria, September 23, 2016.  

Polymyxins, What Do We Really Know? Allergan Medical Affairs, Jersey City, NJ, June 30, 2016.

Lipoglycopeptides and Glycopeptides (symposium). “Antimicrobial Toxicodynamics (Organized in Cooperation with the International Society of Anti-Infective Pharmacology (ISAP).”
ASM Microbes 2016, Boston, MA, June 20, 2016.  

Economics of Treating ABSSI in Different Settings of Care (satellite symposium). Making a Difference (MAD) - ID Annual Meeting, Champions Gate, FL, May 6, 2016.

Quantifying Antibiotic Exposure-Effect Relationships in Patients with Infections:
A Focus on Beta-Lactams and Vancomycin. Midwestern University, Downers Grove, IL, April 15, 2016.

Advanced Pharmacokinetics/Pharmacodynamics (continuing education). New York State Council of Health-system Antimicrobial Stewardship Program, Hosted by Greater New York Hospital Association, New York, NY, March 16, 2016.

Combination Therapy for Serious Gram-Negative Infections (continuing education). New York State Council of Health-system Antimicrobial Stewardship Program, Hosted by Greater New York Hospital Association, New York, NY, March 16, 2016.

Nimish Patel
Patel N. Medication Errors in HIV. Continuing Education. Onondaga Pharmacists Society, Syracuse, NY, June 2016.

Patel N. Medication Errors in HIV. Continuing Education. Capital Area Pharmacists Society, Albany, NY, September 2016.

Patel N. Updates in Epidemiology and Treatment of Sexually Transmitted Infections. Continuing Education. ACPHS, Albany, NY, September 2016.

Patel N. Medication Errors in HIV. Continuing Education. Pharmacists’ Society of the State of New York Annual Meeting, Rye Brook, NY, June 2016.

Patel N. Medication Errors in HIV. Continuing Education. Telemedicine series broadcast to all New York State Department of Corrections pharmacists, Albany Medical Center HIV Clinic, Albany, NY, June 2016.

Patel N. Updates in Epidemiology and Treatment of Hepatitis C Infection. Continuing Education. ACPHS, Albany, NY, February 2016.

Patel N. Updates in Epidemiology and Treatment of HIV. Continuing Education. ACPHS, Albany, NY, February 2016.

Joanna Schwartz
Schwartz J. Oral chemotherapy safety and adherence. Northern New England Chapter of the American Society of Clinical Oncology (NNECOS), October 26, 2016, Bretton Woods, NH.

Schwartz J. Assessment of herbal, dietary supplement and OTC medications with chemotherapy. University of Vermont Breast Symposium, Burlington, VT, October 4, 2016.

Schwartz J. New Drug Update. Northern New England Chapter of the American Society of Clinical Oncology, October 28, 2016, Bretton Woods, NH.

See-Won Seo
Performance-Enhancing Drugs. Continuing Education. ACPHS, Albany, NY, Sept 2016.

New Drug Update. Continuing Education. Pharmacists Society of the State of New York Mid-Winter Conference, Saratoga Springs, NY, Jan 2016.

Matthew Stryker
Part II: Starting Non-Insulin Medication in the Primary Care Setting for Type 2 Diabetes. American Diabetes Association – Innovations in Diabetes Care Annual Meeting, Troy, NY, November 10, 2016.

Alexandra Watson
Watson A. Comprehensive Primary Care (CPC) Leading Innovation, Inspiring Engagement. New York Region Full Day Learning Session, October 2016 (panelist).

Watson A. CapitalCare Medical Group Diabetes Support Group: Ask a Pharmacist. September 2016.

Watson A. Updates on Diabetes: A Focus on Guidelines and Pharmacotherapy. Continuing Education. ACPHS, Albany, NY, June 2016.

Watson A. Life on Rotations, APhA-ASP student chapter meeting, ACPHS, Albany, NY, May 2016.

Watson A. CapitalCare Medical Group Diabetes Support Group: Diabetes Medications and Neuropathy. January 2016.

Grants

Katie Cardone
Principal Investigator: Wendy M. Parker
Co-Principal Investigator: Katie E. Cardone
Project: Health disparities and medication management strategies among adolescents and young adults with Diabetes Mellitus
Grantor: John Faunce and Alicia Tracy Roach Fund
Amount: $24,943.36

Michael Kane, Matthew Stryker, Robert Hamilton
Project: A Real World, Observational Study of Weekly Exenatide Added to Basal Insulin in Patients with Type 2 Diabetes Mellitus
Grantor: AstraZeneca Pharmaceuticals, LP
Amount: $67,387
Awarded: July 2016

See-Won Seo, Jacqueline Cleary
Principal Investigator: See-Won Seo
Co-Principal Investigator: Jacqueline Cleary
Project: A System’s Approach to Reducing the Burden of Asthma in New York State
Grantor: Whitney M Young Jr. Health Center
Amount: $12,800
Awarded: June 2016

Thomas Lodise
Project: Antibacterial Resistance Leadership Group: Minocycline PK in IC Patients
Grantor: Duke University, National Institute of Allergy and Infectious Diseases (NIAID)
Amount: $35,802
Term: December 1, 2016 - November 30, 2017

Honors and Appointments

Jeffrey Brewer
Fellow of the American Society of Health-System Pharmacists, 2016

Gina Garrison
National Secretary, Rho Chi Academic Honor Society, 2011-present

Jacqueline Cleary
2016 PAINWeek Scholarship Recipient

Nicole Lodise
American Association of Colleges of Pharmacy (AACP). Member, Tobacco Control Committee, Public Health Special Interest Group (2016- present).

American Association of Colleges of Pharmacy (AACP). Faculty Champion, Joint Council of Deans/Council of Faculties “Catalyst Team to Integrate the Joint Commission of Pharmacy Practitioners (JCPP) Pharmacists Patient Care Process (PPCP)” (2016-present).

American Association of Colleges of Pharmacy (AACP). Chair, Council of Faculties - Faculty Affairs Committee (COF-FAC) Workgroup on Curricular Adoption and Integration of the Pharmacists’ Patient Care Process (2015-2016).

American Association of Colleges of Pharmacy (AACP). Chair, Section of Teachers of Pharmacy Practice Faculty Development Committee (Chair- 2016-present).

American College of Clinical Pharmacy (ACCP). Member, Educational Affairs Committee (2016- present).

Nimish Patel
Society of Infectious Diseases Pharmacists: Impact Paper of the Year